{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:04:04Z","timestamp":1793696644068,"version":"4.5.1"},"reference-count":269,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["2013\/11\/N\/NZ4\/02233"],"award-info":[{"award-number":["2013\/11\/N\/NZ4\/02233"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIA AG038834"],"award-info":[{"award-number":["NIA AG038834"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004821","name":"Instytut Medycyny Doswiadczalnej i Klinicznej im. M. Mossakowskiego, Polskiej Akademii Nauk","doi-asserted-by":"publisher","award":["T. No 7"],"award-info":[{"award-number":["T. No 7"]}],"id":[{"id":"10.13039\/501100004821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12035-018-1448-3","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T05:26:54Z","timestamp":1546666014000},"page":"5436-5455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":283,"title":["The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer\u2019s Disease and Other Neurodegenerative Disorders"],"prefix":"10.1007","volume":"56","author":[{"given":"Kinga","family":"Czubowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"J\u0119\u015bko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Wencel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Lukiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-0295","authenticated-orcid":false,"given":"Robert P.","family":"Strosznajder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"key":"1448_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad B, Amouyel P, Andrieu S et al (2016) Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol 15:455\u2013532. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(16)00062-4","journal-title":"Lancet Neurol"},{"key":"1448_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fncel.2014.00283","volume":"8","author":"R Brunkhorst","year":"2014","unstructured":"Brunkhorst R, Vutukuri R, Pfeilschifter W (2014) Fingolimod for the treatment of neurological diseases-state of play and future perspectives. Front Cell Neurosci 8:283. \n                    https:\/\/doi.org\/10.3389\/fncel.2014.00283","journal-title":"Front Cell Neurosci"},{"key":"1448_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21037\/atm.2018.04.23","volume":"6","author":"Y-L Gao","year":"2018","unstructured":"Gao Y-L, Wang N, Sun F-R et al (2018) Tau in neurodegenerative disease. Ann Transl Med 6:175. \n                    https:\/\/doi.org\/10.21037\/atm.2018.04.23","journal-title":"Ann Transl Med"},{"key":"1448_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/13543776.2017.1261112","volume":"27","author":"H J\u0119\u015bko","year":"2017","unstructured":"J\u0119\u015bko H, Lenkiewicz AM, Adamczyk A (2017) Treatments and compositions targeting \u03b1-synuclein: a patent review (2010-2016). Expert Opin Ther Pat 27:427\u2013438. \n                    https:\/\/doi.org\/10.1080\/13543776.2017.1261112","journal-title":"Expert Opin Ther Pat"},{"key":"1448_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5:525\u2013535. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"key":"1448_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M et al (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13:217\u2013231. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2017.27","journal-title":"Nat Rev Neurol"},{"key":"1448_CR7","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/J.CHEMPHYSLIP.2011.05.023","volume":"164","author":"S Nakamura","year":"2011","unstructured":"Nakamura S, Fukai E, Miya S et al (2011) Sphingolipid signaling and neuronal function. Chem Phys Lipids 164:S9. \n                    https:\/\/doi.org\/10.1016\/J.CHEMPHYSLIP.2011.05.023","journal-title":"Chem Phys Lipids"},{"key":"1448_CR8","doi-asserted-by":"publisher","unstructured":"J\u0119\u015bko H, St\u0119pie\u0144 A, Lukiw WJ, Strosznajder RP (2018) The cross-talk between sphingolipids and insulin-like growth factor signaling: significance for aging and neurodegeneration. Mol Neurobiol \n                    https:\/\/doi.org\/10.1007\/s12035-018-1286-3","DOI":"10.1007\/s12035-018-1286-3"},{"key":"1448_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00018-012-1038-x","volume":"70","author":"C Mencarelli","year":"2013","unstructured":"Mencarelli C, Martinez-Martinez P (2013) Ceramide function in the brain: when a slight tilt is enough. Cell Mol Life Sci 70:181\u2013203. \n                    https:\/\/doi.org\/10.1007\/s00018-012-1038-x","journal-title":"Cell Mol Life Sci"},{"key":"1448_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","volume":"510","author":"M Maceyka","year":"2014","unstructured":"Maceyka M, Spiegel S (2014) Sphingolipid metabolites in inflammatory disease. Nature 510:58\u201367. \n                    https:\/\/doi.org\/10.1038\/nature13475","journal-title":"Nature"},{"key":"1448_CR11","doi-asserted-by":"publisher","unstructured":"Airola MV, Hannun YA (2013) Sphingolipid metabolism and neutral sphingomyelinases. In: Gulbins E., Petrache I. (eds) Sphingolipids: Basic Science and Drug Development. Handb Exp Pharmacol 215:57\u201376. Springer, Vienna. \n                    https:\/\/doi.org\/10.1007\/978-3-7091-1368-4_3","DOI":"10.1007\/978-3-7091-1368-4_3"},{"key":"1448_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.pharep.2018.05.002","volume":"70","author":"J Motyl","year":"2018","unstructured":"Motyl J, Strosznajder JB (2018) Sphingosine kinase 1\/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson\u2019s disease. Pharmacol Rep 70:1010\u20131014. \n                    https:\/\/doi.org\/10.1016\/j.pharep.2018.05.002","journal-title":"Pharmacol Rep"},{"key":"1448_CR13","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/cdd.2011.7","volume":"18","author":"N Hagen","year":"2011","unstructured":"Hagen N, Hans M, Hartmann D et al (2011) Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism. Cell Death Differ 18:1356\u20131365. \n                    https:\/\/doi.org\/10.1038\/cdd.2011.7","journal-title":"Cell Death Differ"},{"key":"1448_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ajhg.2010.09.010","volume":"87","author":"A Rotthier","year":"2010","unstructured":"Rotthier A, Auer-Grumbach M, Janssens K et al (2010) Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am J Hum Genet 87:513\u2013522. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2010.09.010","journal-title":"Am J Hum Genet"},{"key":"1448_CR15","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1073\/pnas.1522071113","volume":"113","author":"SD Spassieva","year":"2016","unstructured":"Spassieva SD, Ji X, Liu Y et al (2016) Ectopic expression of ceramide synthase 2 in neurons suppresses neurodegeneration induced by ceramide synthase 1 deficiency. Proc Natl Acad Sci U S A 113:5928\u20135933. \n                    https:\/\/doi.org\/10.1073\/pnas.1522071113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1448_CR16","doi-asserted-by":"publisher","first-page":"e1002063","DOI":"10.1371\/journal.pgen.1002063","volume":"7","author":"L Zhao","year":"2011","unstructured":"Zhao L, Spassieva SD, Jucius TJ et al (2011) A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation. PLoS Genet 7:e1002063. \n                    https:\/\/doi.org\/10.1371\/journal.pgen.1002063","journal-title":"PLoS Genet"},{"key":"1448_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/icb.2015.47","volume":"93","author":"M Eberle","year":"2015","unstructured":"Eberle M, Ebel P, Mayer CA et al (2015) Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation\/migration of neutrophils. Immunol Cell Biol 93:825\u2013836. \n                    https:\/\/doi.org\/10.1038\/icb.2015.47","journal-title":"Immunol Cell Biol"},{"key":"1448_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","volume":"12","author":"MM McGovern","year":"2017","unstructured":"McGovern MM, Avetisyan R, Sanson B-J, Lidove O (2017) Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD). Orphanet J Rare Dis 12:41. \n                    https:\/\/doi.org\/10.1186\/s13023-017-0572-x","journal-title":"Orphanet J Rare Dis"},{"key":"1448_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajpath.2016.12.005","volume":"187","author":"J Sikora","year":"2017","unstructured":"Sikora J, Dworski S, Jones EE et al (2017) Acid ceramidase deficiency in mice results in a broad range of central nervous system abnormalities. Am J Pathol 187:864\u2013883. \n                    https:\/\/doi.org\/10.1016\/j.ajpath.2016.12.005","journal-title":"Am J Pathol"},{"key":"1448_CR20","doi-asserted-by":"publisher","first-page":"e1005591","DOI":"10.1371\/journal.pgen.1005591","volume":"11","author":"K Wang","year":"2015","unstructured":"Wang K, Xu R, Schrandt J et al (2015) Alkaline ceramidase 3 deficiency results in Purkinje cell degeneration and cerebellar Ataxia due to dyshomeostasis of sphingolipids in the brain. PLoS Genet 11:e1005591. \n                    https:\/\/doi.org\/10.1371\/journal.pgen.1005591","journal-title":"PLoS Genet"},{"key":"1448_CR21","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1113\/jphysiol.2012.235846","volume":"590","author":"M-H Lu","year":"2012","unstructured":"Lu M-H, Takemoto M, Watanabe K et al (2012) Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice. J Physiol 590:4029\u20134044. \n                    https:\/\/doi.org\/10.1113\/jphysiol.2012.235846","journal-title":"J Physiol"},{"key":"1448_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbr.2016.11.010","volume":"319","author":"M Wang","year":"2017","unstructured":"Wang M, Uchiumi O, Ogiso H et al (2017) Stressful learning paradigm precludes manifestation of cognitive ability in sphingomyelin synthase-2 knockout mice. Behav Brain Res 319:25\u201330. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2016.11.010","journal-title":"Behav Brain Res"},{"key":"1448_CR23","doi-asserted-by":"publisher","first-page":"10690","DOI":"10.1074\/jbc.M700370200","volume":"282","author":"M Kono","year":"2007","unstructured":"Kono M, Belyantseva IA, Skoura A et al (2007) Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem 282:10690\u201310696. \n                    https:\/\/doi.org\/10.1074\/jbc.M700370200","journal-title":"J Biol Chem"},{"key":"1448_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.0953-816x.2001.01634.x","volume":"14","author":"AJ MacLennan","year":"2001","unstructured":"MacLennan AJ, Carney PR, Zhu WJ et al (2001) An essential role for the H218\/AGR16\/Edg-5\/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. Eur J Neurosci 14:203\u2013209","journal-title":"Eur J Neurosci"},{"key":"1448_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mad.2014.11.002","volume":"143\u2013144","author":"RG Cutler","year":"2014","unstructured":"Cutler RG, Thompson KW, Camandola S et al (2014) Sphingolipid metabolism regulates development and lifespan in Caenorhabditis elegans. Mech Ageing Dev 143\u2013144:9\u201318. \n                    https:\/\/doi.org\/10.1016\/j.mad.2014.11.002","journal-title":"Mech Ageing Dev"},{"key":"1448_CR26","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00018-010-0260-7","volume":"67","author":"Q Yang","year":"2010","unstructured":"Yang Q, Gong Z-J, Zhou Y et al (2010) Role of Drosophila alkaline ceramidase (Dacer) in Drosophila development and longevity. Cell Mol Life Sci 67:1477\u20131490. \n                    https:\/\/doi.org\/10.1007\/s00018-010-0260-7","journal-title":"Cell Mol Life Sci"},{"key":"1448_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/gerona\/glw048","volume":"72","author":"M Jov\u00e9","year":"2017","unstructured":"Jov\u00e9 M, Naud\u00ed A, Gambini J et al (2017) A stress-resistant Lipidomic signature confers extreme longevity to humans. J Gerontol A Biol Sci Med Sci 72:30\u201337. \n                    https:\/\/doi.org\/10.1093\/gerona\/glw048","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1448_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neurobiolaging.2016.03.027","volume":"43","author":"TA Couttas","year":"2016","unstructured":"Couttas TA, Kain N, Suchowerska AK et al (2016) Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer\u2019s disease. Neurobiol Aging 43:89\u2013100. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.03.027","journal-title":"Neurobiol Aging"},{"key":"1448_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","volume":"82","author":"XM Han","year":"2002","unstructured":"Han XM, Holtzman D, McKeel DW et al (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis. J Neurochem 82:809\u2013818","journal-title":"J Neurochem"},{"key":"1448_CR30","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.3390\/ijms15034356","volume":"15","author":"P Giussani","year":"2014","unstructured":"Giussani P, Tringali C, Riboni L et al (2014) Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance. Int J Mol Sci 15:4356\u20134392. \n                    https:\/\/doi.org\/10.3390\/ijms15034356","journal-title":"Int J Mol Sci"},{"key":"1448_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","volume":"113","author":"S O\u2019Sullivan","year":"2017","unstructured":"O\u2019Sullivan S, Dev KK (2017) Sphingosine-1-phosphate receptor therapies: advances in clinical trials for CNS-related diseases. Neuropharmacology 113:597\u2013607. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2016.11.006","journal-title":"Neuropharmacology"},{"key":"1448_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cellsig.2008.11.003","volume":"21","author":"MH Granado","year":"2009","unstructured":"Granado MH, Gangoiti P, Ouro A et al (2009) Ceramide 1-phosphate (C1P) promotes cell migration involvement of a specific C1P receptor. Cell Signal 21:405\u2013412. \n                    https:\/\/doi.org\/10.1016\/j.cellsig.2008.11.003","journal-title":"Cell Signal"},{"key":"1448_CR33","doi-asserted-by":"publisher","unstructured":"Abdelbaset-Ismail A, Cymer M, Borkowska-Rzeszotek S, et al (2018) Bioactive phospholipids enhance migration and adhesion of human leukemic cells by inhibiting Heme oxygenase 1 (HO-1) and inducible nitric oxygenase synthase (iNOS) in a p38 MAPK-dependent manner. Stem Cell Rev \n                    https:\/\/doi.org\/10.1007\/s12015-018-9853-6","DOI":"10.1007\/s12015-018-9853-6"},{"key":"1448_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/651727","volume":"2014","author":"M Nagahashi","year":"2014","unstructured":"Nagahashi M, Takabe K, Terracina KP et al (2014) Sphingosine-1-phosphate transporters as targets for cancer therapy. Biomed Res Int 2014:1\u20137. \n                    https:\/\/doi.org\/10.1155\/2014\/651727","journal-title":"Biomed Res Int"},{"key":"1448_CR35","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.bbalip.2010.02.002","volume":"1801","author":"AA Farooqui","year":"2010","unstructured":"Farooqui AA, Ong W-Y, Farooqui T (2010) Lipid mediators in the nucleus: their potential contribution to Alzheimer\u2019s disease. Biochim Biophys Acta 1801:906\u2013916. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2010.02.002","journal-title":"Biochim Biophys Acta"},{"key":"1448_CR36","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1038\/cddis.2013.455","volume":"4","author":"C Rutherford","year":"2013","unstructured":"Rutherford C, Childs S, Ohotski J et al (2013) Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase\/protein kinase C-mediated upregulation of Mcl-1. Cell Death Dis 4:e927. \n                    https:\/\/doi.org\/10.1038\/cddis.2013.455","journal-title":"Cell Death Dis"},{"key":"1448_CR37","doi-asserted-by":"publisher","first-page":"346783","DOI":"10.1155\/2015\/346783","volume":"2015","author":"M Jazvin\u0161\u0107ak Jembrek","year":"2015","unstructured":"Jazvin\u0161\u0107ak Jembrek M, Hof PR, \u0160imi\u0107 G (2015) Ceramides in Alzheimer\u2019s disease: key mediators of neuronal apoptosis induced by oxidative stress and A\u03b2 accumulation. Oxidative Med Cell Longev 2015:346783. \n                    https:\/\/doi.org\/10.1155\/2015\/346783","journal-title":"Oxidative Med Cell Longev"},{"key":"1448_CR38","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.bbalip.2006.06.004","volume":"1761","author":"CF Snook","year":"2006","unstructured":"Snook CF, Jones JA, Hannun YA (2006) Sphingolipid-binding proteins. Biochim Biophys Acta 1761:927\u2013946. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2006.06.004","journal-title":"Biochim Biophys Acta"},{"key":"1448_CR39","doi-asserted-by":"publisher","first-page":"18440","DOI":"10.18632\/oncotarget.7825","volume":"7","author":"R Xu","year":"2016","unstructured":"Xu R, Wang K, Mileva I et al (2016) Alkaline ceramidase 2 and its bioactive product sphingosine are novel regulators of the DNA damage response. Oncotarget 7:18440\u201318457. \n                    https:\/\/doi.org\/10.18632\/oncotarget.7825","journal-title":"Oncotarget"},{"key":"1448_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1194\/jlr.M300158-JLR200","volume":"45","author":"A G\u00f3mez-Mu\u00f1oz","year":"2004","unstructured":"G\u00f3mez-Mu\u00f1oz A, Kong JY, Salh B, Steinbrecher UP (2004) Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J Lipid Res 45:99\u2013105. \n                    https:\/\/doi.org\/10.1194\/jlr.M300158-JLR200","journal-title":"J Lipid Res"},{"key":"1448_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbalip.2009.01.023","volume":"1791","author":"MH Granado","year":"2009","unstructured":"Granado MH, Gangoiti P, Ouro A et al (2009) Ceramide 1-phosphate inhibits serine palmitoyltransferase and blocks apoptosis in alveolar macrophages. Biochim Biophys Acta 1791:263\u2013272. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2009.01.023","journal-title":"Biochim Biophys Acta"},{"key":"1448_CR42","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/toxins7051457","volume":"7","author":"I-G Rivera","year":"2015","unstructured":"Rivera I-G, Ordo\u00f1ez M, Presa N et al (2015) Sphingomyelinase D\/ceramide 1-phosphate in cell survival and inflammation. Toxins (Basel) 7:1457\u20131466. \n                    https:\/\/doi.org\/10.3390\/toxins7051457","journal-title":"Toxins (Basel)"},{"key":"1448_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbalip.2012.07.015","volume":"1831","author":"JW Choi","year":"2013","unstructured":"Choi JW, Chun J (2013) Lysophospholipids and their receptors in the central nervous system. Biochim Biophys Acta - Mol Cell Biol Lipids 1831:20\u201332. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2012.07.015","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"1448_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JAD-171054","volume":"63","author":"TA Couttas","year":"2018","unstructured":"Couttas TA, Kain N, Tran C et al (2018) Age-dependent changes to sphingolipid balance in the human hippocampus are gender-specific and may sensitize to neurodegeneration. J Alzheimers Dis 63:503\u2013514. \n                    https:\/\/doi.org\/10.3233\/JAD-171054","journal-title":"J Alzheimers Dis"},{"key":"1448_CR45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5114\/fn.2014.45567","volume":"52","author":"JA Pyszko","year":"2014","unstructured":"Pyszko JA, Strosznajder JB (2014) The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson\u2019s disease. Folia Neuropathol 52:260\u2013269","journal-title":"Folia Neuropathol"},{"key":"1448_CR46","doi-asserted-by":"publisher","first-page":"S586","DOI":"10.1016\/S0924-977X(15)30824-5","volume":"25","author":"J Motyl","year":"2015","unstructured":"Motyl J, Przykaza \u0141, Kosson P, Boguszewski P, Strosznajder J (2015) P.5.c.002 sphingosine kinase 1 mediated signalling in Parkinson\u2019s disease animal model. Neuroprotective effect of fingolimod and a D2\/D3 dopamine receptor agonist. Eur Neuropsychopharmacol 25:S586\u2013S587. \n                    https:\/\/doi.org\/10.1016\/S0924-977X(15)30824-5","journal-title":"Eur Neuropsychopharmacol"},{"key":"1448_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12035-013-8606-4","volume":"50","author":"K Czubowicz","year":"2014","unstructured":"Czubowicz K, Strosznajder R (2014) Ceramide in the molecular mechanisms of neuronal cell death. The role of sphingosine-1-phosphate. Mol Neurobiol 50:26\u201337. \n                    https:\/\/doi.org\/10.1007\/s12035-013-8606-4","journal-title":"Mol Neurobiol"},{"key":"1448_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cellsig.2013.12.002","volume":"26","author":"K Huang","year":"2014","unstructured":"Huang K, Huang J, Chen C et al (2014) AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose. Cell Signal 26:629\u2013638. \n                    https:\/\/doi.org\/10.1016\/j.cellsig.2013.12.002","journal-title":"Cell Signal"},{"key":"1448_CR49","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.bcp.2014.10.007","volume":"92","author":"M-S Wegner","year":"2014","unstructured":"Wegner M-S, Wanger RA, Oertel S et al (2014) Ceramide synthases CerS4 and CerS5 are upregulated by 17\u03b2-estradiol and GPER1 via AP-1 in human breast cancer cells. Biochem Pharmacol 92:577\u2013589. \n                    https:\/\/doi.org\/10.1016\/j.bcp.2014.10.007","journal-title":"Biochem Pharmacol"},{"key":"1448_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.abb.2011.04.009","volume":"511","author":"SM O\u2019Neill","year":"2011","unstructured":"O\u2019Neill SM, Houck KL, Yun JK et al (2011) AP-1 binding transcriptionally regulates human neutral ceramidase. Arch Biochem Biophys 511:31\u201339. \n                    https:\/\/doi.org\/10.1016\/j.abb.2011.04.009","journal-title":"Arch Biochem Biophys"},{"key":"1448_CR51","doi-asserted-by":"publisher","first-page":"13297","DOI":"10.1074\/jbc.275.18.13297","volume":"275","author":"SK Manna","year":"2000","unstructured":"Manna SK, Sah NK, Aggarwal BB (2000) Protein tyrosine kinase p56lck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-kappa B, AP-1, JNK, and apoptosis. J Biol Chem 275:13297\u201313306","journal-title":"J Biol Chem"},{"key":"1448_CR52","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1111\/jcmm.13596","volume":"22","author":"Y-F Dong","year":"2018","unstructured":"Dong Y-F, Guo R-B, Ji J et al (2018) S1PR3 is essential for phosphorylated fingolimod to protect astrocytes against oxygen-glucose deprivation-induced neuroinflammation via inhibiting TLR2\/4-NF\u03baB signalling. J Cell Mol Med 22:3159\u20133166. \n                    https:\/\/doi.org\/10.1111\/jcmm.13596","journal-title":"J Cell Mol Med"},{"key":"1448_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.redox.2015.06.019","volume":"6","author":"L-O Klotz","year":"2015","unstructured":"Klotz L-O, S\u00e1nchez-Ramos C, Prieto-Arroyo I et al (2015) Redox regulation of FOXO transcription factors. Redox Biol 6:51\u201372. \n                    https:\/\/doi.org\/10.1016\/j.redox.2015.06.019","journal-title":"Redox Biol"},{"key":"1448_CR54","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2174\/1567202614666171116102911","volume":"14","author":"K Maiese","year":"2018","unstructured":"Maiese K (2018) Forkhead transcription factors: formulating a FOXO target for cognitive loss. Curr Neurovasc Res 14:415\u2013420. \n                    https:\/\/doi.org\/10.2174\/1567202614666171116102911","journal-title":"Curr Neurovasc Res"},{"key":"1448_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/J.BIOCHI.2013.07.027","volume":"100","author":"A Kogot-Levin","year":"2014","unstructured":"Kogot-Levin A, Saada A (2014) Ceramide and the mitochondrial respiratory chain. Biochimie 100:88\u201394. \n                    https:\/\/doi.org\/10.1016\/J.BIOCHI.2013.07.027","journal-title":"Biochimie"},{"key":"1448_CR56","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.mcn.2005.02.009","volume":"29","author":"BA Stoica","year":"2005","unstructured":"Stoica BA, Movsesyan VA, Knoblach SM, Faden AI (2005) Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins. Mol Cell Neurosci 29:355\u2013371. \n                    https:\/\/doi.org\/10.1016\/j.mcn.2005.02.009","journal-title":"Mol Cell Neurosci"},{"key":"1448_CR57","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nchembio.1059","volume":"8","author":"RD Sentelle","year":"2012","unstructured":"Sentelle RD, Senkal CE, Jiang W et al (2012) Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nat Chem Biol 8:831\u2013838. \n                    https:\/\/doi.org\/10.1038\/nchembio.1059","journal-title":"Nat Chem Biol"},{"key":"1448_CR58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.bbalip.2013.09.005","volume":"1841","author":"W Jiang","year":"2014","unstructured":"Jiang W, Ogretmen B (2014) Autophagy paradox and ceramide. Biochim Biophys Acta - Mol Cell Biol Lipids 1841:783\u2013792. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2013.09.005","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"1448_CR59","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.1176709","volume":"325","author":"NC Hait","year":"2009","unstructured":"Hait NC, Allegood J, Maceyka M et al (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325:1254\u20131257. \n                    https:\/\/doi.org\/10.1126\/science.1176709","journal-title":"Science"},{"key":"1448_CR60","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1089\/jop.2017.0059","volume":"34","author":"HM Schmitt","year":"2018","unstructured":"Schmitt HM, Schlamp CL, Nickells RW (2018) Targeting HDAC3 activity with RGFP966 protects against retinal ganglion cell nuclear atrophy and apoptosis after optic nerve injury. J Ocul Pharmacol Ther 34:260\u2013273. \n                    https:\/\/doi.org\/10.1089\/jop.2017.0059","journal-title":"J Ocul Pharmacol Ther"},{"key":"1448_CR61","doi-asserted-by":"publisher","first-page":"56767","DOI":"10.18632\/oncotarget.10790","volume":"7","author":"M-H Jeong","year":"2016","unstructured":"Jeong M-H, Ko H, Jeon H et al (2016) Delphinidin induces apoptosis via cleaved HDAC3-mediated p53 acetylation and oligomerization in prostate cancer cells. Oncotarget 7:56767\u201356780. \n                    https:\/\/doi.org\/10.18632\/oncotarget.10790","journal-title":"Oncotarget"},{"key":"1448_CR62","doi-asserted-by":"publisher","first-page":"201712918","DOI":"10.1073\/pnas.1712918115","volume":"115","author":"S-H Lee","year":"2018","unstructured":"Lee S-H, Seo J, Park S-Y et al (2018) Programmed cell death 5 suppresses AKT-mediated cytoprotection of endothelium. Proc Natl Acad Sci 115:201712918. \n                    https:\/\/doi.org\/10.1073\/pnas.1712918115","journal-title":"Proc Natl Acad Sci"},{"key":"1448_CR63","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.nbd.2006.02.010","volume":"23","author":"C Malaplate-Armand","year":"2006","unstructured":"Malaplate-Armand C, Florent-B\u00e9chard S, Youssef I et al (2006) Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. Neurobiol Dis 23:178\u2013189. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2006.02.010","journal-title":"Neurobiol Dis"},{"key":"1448_CR64","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.RES.0000253900.66640.34","volume":"100","author":"D Pchejetski","year":"2007","unstructured":"Pchejetski D, Kunduzova O, Dayon A et al (2007) Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circ Res 100:41\u201349. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000253900.66640.34","journal-title":"Circ Res"},{"key":"1448_CR65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2051-5960-2-9","volume":"2","author":"TA Couttas","year":"2014","unstructured":"Couttas TA, Kain N, Daniels B et al (2014) Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer\u2019s disease pathogenesis. Acta Neuropathol Commun 2:9. \n                    https:\/\/doi.org\/10.1186\/2051-5960-2-9","journal-title":"Acta Neuropathol Commun"},{"key":"1448_CR66","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1007\/s12035-014-8807-5","volume":"51","author":"K Czubowicz","year":"2015","unstructured":"Czubowicz K, Cie\u015blik M, Pyszko J et al (2015) Sphingosine-1-phosphate and its effect on glucose deprivation\/glucose reload stress: from gene expression to neuronal survival. Mol Neurobiol 51:1300\u20131308. \n                    https:\/\/doi.org\/10.1007\/s12035-014-8807-5","journal-title":"Mol Neurobiol"},{"key":"1448_CR67","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cbpb.2012.05.006","volume":"163","author":"JR Van Brocklyn","year":"2012","unstructured":"Van Brocklyn JR, Williams JB (2012) The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death. Comp Biochem Physiol B Biochem Mol Biol 163:26\u201336. \n                    https:\/\/doi.org\/10.1016\/j.cbpb.2012.05.006","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"1448_CR68","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3892\/ijmm.2016.2731","volume":"38","author":"W Chen","year":"2016","unstructured":"Chen W, Lu H, Yang J et al (2016) Sphingosine 1-phosphate in metabolic syndrome (review). Int J Mol Med 38:1030\u20131038. \n                    https:\/\/doi.org\/10.3892\/ijmm.2016.2731","journal-title":"Int J Mol Med"},{"key":"1448_CR69","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/STROKEAHA.109.568899","volume":"41","author":"Y Hasegawa","year":"2010","unstructured":"Hasegawa Y, Suzuki H, Sozen T et al (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41:368\u2013374. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.109.568899","journal-title":"Stroke"},{"key":"1448_CR70","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12031-014-0478-1","volume":"56","author":"F Safarian","year":"2015","unstructured":"Safarian F, Khallaghi B, Ahmadiani A, Dargahi L (2015) Activation of S1P1 receptor regulates PI3K\/Akt\/FOXO3a pathway in response to oxidative stress in PC12 cells. J Mol Neurosci 56:177\u2013187. \n                    https:\/\/doi.org\/10.1007\/s12031-014-0478-1","journal-title":"J Mol Neurosci"},{"key":"1448_CR71","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","volume":"31","author":"AM Moloney","year":"2010","unstructured":"Moloney AM, Griffin RJ, Timmons S et al (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31:224\u2013243. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.04.002","journal-title":"Neurobiol Aging"},{"key":"1448_CR72","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cellsig.2015.02.018","volume":"27","author":"M-A Lauzon","year":"2015","unstructured":"Lauzon M-A, Daviau A, Marcos B, Faucheux N (2015) Growth factor treatment to overcome Alzheimer\u2019s dysfunctional signaling. Cell Signal 27:1025\u20131038. \n                    https:\/\/doi.org\/10.1016\/j.cellsig.2015.02.018","journal-title":"Cell Signal"},{"key":"1448_CR73","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/jcp.24795","volume":"230","author":"C-K Hsu","year":"2015","unstructured":"Hsu C-K, Lee I-T, Lin C-C et al (2015) Sphingosine-1-phosphate mediates COX-2 expression and PGE2 \/IL-6 secretion via c-Src-dependent AP-1 activation. J Cell Physiol 230:702\u2013715. \n                    https:\/\/doi.org\/10.1002\/jcp.24795","journal-title":"J Cell Physiol"},{"key":"1448_CR74","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/nature09128","volume":"465","author":"SE Alvarez","year":"2010","unstructured":"Alvarez SE, Harikumar KB, Hait NC et al (2010) Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465:1084\u20131088. \n                    https:\/\/doi.org\/10.1038\/nature09128","journal-title":"Nature"},{"key":"1448_CR75","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1074\/jbc.M111423200","volume":"277","author":"P Xia","year":"2002","unstructured":"Xia P, Wang L, Moretti PAB et al (2002) Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling. J Biol Chem 277:7996\u20138003. \n                    https:\/\/doi.org\/10.1074\/jbc.M111423200","journal-title":"J Biol Chem"},{"key":"1448_CR76","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/MCB.25.13.5429-5444.2005","volume":"25","author":"Y Dai","year":"2005","unstructured":"Dai Y, Rahmani M, Dent P, Grant S (2005) Blockade of histone deacetylase inhibitor-induced RelA\/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation. Mol Cell Biol 25:5429\u20135444. \n                    https:\/\/doi.org\/10.1128\/MCB.25.13.5429-5444.2005","journal-title":"Mol Cell Biol"},{"key":"1448_CR77","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neurobiolaging.2014.07.035","volume":"36","author":"Y Wang","year":"2015","unstructured":"Wang Y, Yang R, Gu J et al (2015) Cross talk between PI3K-AKT-GSK-3\u03b2 and PP2A pathways determines tau hyperphosphorylation. Neurobiol Aging 36:188\u2013200. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.035","journal-title":"Neurobiol Aging"},{"key":"1448_CR78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.phrs.2015.11.006","volume":"104","author":"R Ghasemi","year":"2016","unstructured":"Ghasemi R, Dargahi L, Ahmadiani A (2016) Integrated sphingosine-1 phosphate signaling in the central nervous system: from physiological equilibrium to pathological damage. Pharmacol Res 104:156\u2013164. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2015.11.006","journal-title":"Pharmacol Res"},{"key":"1448_CR79","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mrrev.2009.01.001","volume":"682","author":"PW Vesely","year":"2009","unstructured":"Vesely PW, Staber PB, Hoefler G, Kenner L (2009) Translational regulation mechanisms of AP-1 proteins. Mutat Res Mutat Res 682:7\u201312. \n                    https:\/\/doi.org\/10.1016\/j.mrrev.2009.01.001","journal-title":"Mutat Res Mutat Res"},{"key":"1448_CR80","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/jnr.21604","volume":"86","author":"N Sawe","year":"2008","unstructured":"Sawe N, Steinberg G, Zhao H (2008) Dual roles of the MAPK\/ERK1\/2 cell signaling pathway after stroke. J Neurosci Res 86:1659\u20131669. \n                    https:\/\/doi.org\/10.1002\/jnr.21604","journal-title":"J Neurosci Res"},{"key":"1448_CR81","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1742-4658.2009.07367.x","volume":"277","author":"S Subramaniam","year":"2010","unstructured":"Subramaniam S, Unsicker K (2010) ERK and cell death: ERK1\/2 in neuronal death. FEBS J 277:22\u201329. \n                    https:\/\/doi.org\/10.1111\/j.1742-4658.2009.07367.x","journal-title":"FEBS J"},{"key":"1448_CR82","first-page":"1541","volume":"7","author":"L Wang","year":"2015","unstructured":"Wang L, Cheng B-F, Yang H-J et al (2015) NF-\u03baB protects human neuroblastoma cells from nitric oxide-induced apoptosis through upregulating biglycan. Am J Transl Res 7:1541\u20131552","journal-title":"Am J Transl Res"},{"key":"1448_CR83","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.brainresbull.2017.07.008","volume":"134","author":"A Kim","year":"2017","unstructured":"Kim A, Nam YJ, Lee CS (2017) Taxifolin reduces the cholesterol oxidation product-induced neuronal apoptosis by suppressing the Akt and NF-\u03baB activation-mediated cell death. Brain Res Bull 134:63\u201371. \n                    https:\/\/doi.org\/10.1016\/j.brainresbull.2017.07.008","journal-title":"Brain Res Bull"},{"key":"1448_CR84","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1096\/fj.201701067R","volume":"32","author":"NU Schwartz","year":"2018","unstructured":"Schwartz NU, Linzer RW, Truman J-P et al (2018) Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F. FASEB J 32:1716\u20131728. \n                    https:\/\/doi.org\/10.1096\/fj.201701067R","journal-title":"FASEB J"},{"key":"1448_CR85","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/BJ20021528","volume":"369","author":"WJ van Blitterswijk","year":"2003","unstructured":"van Blitterswijk WJ, van der Luit AH, Veldman RJ et al (2003) Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J 369:199\u2013211. \n                    https:\/\/doi.org\/10.1042\/BJ20021528","journal-title":"Biochem J"},{"key":"1448_CR86","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.cellsig.2010.04.006","volume":"22","author":"J Mesicek","year":"2010","unstructured":"Mesicek J, Lee H, Feldman T et al (2010) Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal 22:1300\u20131307. \n                    https:\/\/doi.org\/10.1016\/j.cellsig.2010.04.006","journal-title":"Cell Signal"},{"key":"1448_CR87","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/15384047.2015.1026509","volume":"16","author":"N Cruickshanks","year":"2015","unstructured":"Cruickshanks N, Roberts JL, Bareford MD et al (2015) Differential regulation of autophagy and cell viability by ceramide species. Cancer Biol Ther 16:733\u2013742. \n                    https:\/\/doi.org\/10.1080\/15384047.2015.1026509","journal-title":"Cancer Biol Ther"},{"key":"1448_CR88","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1128\/IAI.70.12.6828-6838.2002","volume":"70","author":"S Ghosh","year":"2002","unstructured":"Ghosh S, Bhattacharyya S, Sirkar M et al (2002) Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect Immun 70:6828\u20136838","journal-title":"Infect Immun"},{"key":"1448_CR89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10863-016-9646-z","volume":"49","author":"M Colombini","year":"2017","unstructured":"Colombini M (2017) Ceramide channels and mitochondrial outer membrane permeability. J Bioenerg Biomembr 49:57\u201364. \n                    https:\/\/doi.org\/10.1007\/s10863-016-9646-z","journal-title":"J Bioenerg Biomembr"},{"key":"1448_CR90","doi-asserted-by":"publisher","first-page":"352723","DOI":"10.1155\/2015\/352723","volume":"2015","author":"Z Liu","year":"2015","unstructured":"Liu Z, Li T, Li P et al (2015) The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer\u2019s disease. Oxidative Med Cell Longev 2015:352723. \n                    https:\/\/doi.org\/10.1155\/2015\/352723","journal-title":"Oxidative Med Cell Longev"},{"key":"1448_CR91","doi-asserted-by":"publisher","first-page":"801","DOI":"10.12659\/MSM.898679","volume":"23","author":"L Zhang","year":"2017","unstructured":"Zhang L, Wang L, Wang R et al (2017) Evaluating the effectiveness of GTM-1, rapamycin, and carbamazepine on autophagy and Alzheimer disease. Med Sci Monit 23:801\u2013808","journal-title":"Med Sci Monit"},{"key":"1448_CR92","doi-asserted-by":"publisher","first-page":"e0180675","DOI":"10.1371\/journal.pone.0180675","volume":"12","author":"R \u0160mid\u00e1k","year":"2017","unstructured":"\u0160mid\u00e1k R, K\u00f6feler HC, Hoeger H, Lubec G (2017) Comprehensive identification of age-related lipidome changes in rat amygdala during normal aging. PLoS One 12:e0180675. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0180675","journal-title":"PLoS One"},{"key":"1448_CR93","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4149\/gpb_2015046","volume":"35","author":"NA Babenko","year":"2016","unstructured":"Babenko NA, Garkavenko VV, Storozhenko GV, Timofiychuk OA (2016) Role of acid sphingomyelinase in the age-dependent dysregulation of sphingolipids turnover in the tissues of rats. Gen Physiol Biophys 35:195\u2013205. \n                    https:\/\/doi.org\/10.4149\/gpb_2015046","journal-title":"Gen Physiol Biophys"},{"key":"1448_CR94","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/acel.12275","volume":"14","author":"MM Mielke","year":"2015","unstructured":"Mielke MM, Bandaru VVR, Han D et al (2015) Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging. Aging Cell 14:112\u2013121. \n                    https:\/\/doi.org\/10.1111\/acel.12275","journal-title":"Aging Cell"},{"key":"1448_CR95","doi-asserted-by":"publisher","first-page":"PE27","DOI":"10.1126\/sageke.2003.39.pe27","volume":"2003","author":"LM Obeid","year":"2003","unstructured":"Obeid LM, Hannun YA (2003) Ceramide, stress, and a \u201clag\u201d in aging. Sci Aging Knowl Environ 2003:PE27. \n                    https:\/\/doi.org\/10.1126\/sageke.2003.39.pe27","journal-title":"Sci Aging Knowl Environ"},{"key":"1448_CR96","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.bbalip.2013.08.006","volume":"1841","author":"X Huang","year":"2014","unstructured":"Huang X, Withers BR, Dickson RC (2014) Sphingolipids and lifespan regulation. Biochim Biophys Acta - Mol Cell Biol Lipids 1841:657\u2013664. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2013.08.006","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"1448_CR97","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.exger.2004.03.026","volume":"39","author":"JC Jiang","year":"2004","unstructured":"Jiang JC, Kirchman PA, Allen M, Jazwinski SM (2004) Suppressor analysis points to the subtle role of the LAG1 ceramide synthase gene in determining yeast longevity. Exp Gerontol 39:999\u20131009. \n                    https:\/\/doi.org\/10.1016\/j.exger.2004.03.026","journal-title":"Exp Gerontol"},{"key":"1448_CR98","doi-asserted-by":"publisher","first-page":"e45890","DOI":"10.1371\/journal.pone.0045890","volume":"7","author":"Y Kim","year":"2012","unstructured":"Kim Y, Sun H (2012) ASM-3 acid sphingomyelinase functions as a positive regulator of the DAF-2\/AGE-1 signaling pathway and serves as a novel anti-aging target. PLoS One 7:e45890. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0045890","journal-title":"PLoS One"},{"key":"1448_CR99","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4049\/jimmunol.167.1.173","volume":"167","author":"Y Osawa","year":"2001","unstructured":"Osawa Y, Banno Y, Nagaki M et al (2001) TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase\/Akt pathway in human hepatocytes. J Immunol 167:173\u2013180","journal-title":"J Immunol"},{"key":"1448_CR100","doi-asserted-by":"publisher","first-page":"13330","DOI":"10.1074\/jbc.275.18.13330","volume":"275","author":"KM Schubert","year":"2000","unstructured":"Schubert KM, Scheid MP, Duronio V (2000) Ceramide inhibits protein kinase B\/Akt by promoting dephosphorylation of serine 473. J Biol Chem 275:13330\u201313335","journal-title":"J Biol Chem"},{"key":"1448_CR101","doi-asserted-by":"publisher","first-page":"E503","DOI":"10.1152\/ajpendo.00262.2015","volume":"309","author":"HM Brown-Borg","year":"2015","unstructured":"Brown-Borg HM (2015) The somatotropic axis and longevity in mice. Am J Physiol Endocrinol Metab 309:E503\u2013E510. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00262.2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1448_CR102","doi-asserted-by":"publisher","first-page":"e16144","DOI":"10.1371\/journal.pone.0016144","volume":"6","author":"C Selman","year":"2011","unstructured":"Selman C, Partridge L, Withers DJ (2011) Replication of extended lifespan phenotype in mice with deletion of insulin receptor substrate 1. PLoS One 6:e16144. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0016144","journal-title":"PLoS One"},{"key":"1448_CR103","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1371\/journal.pbio.0060254","volume":"6","author":"L Kappeler","year":"2008","unstructured":"Kappeler L, Filho CDM, Dupont J et al (2008) Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biol 6:e254. \n                    https:\/\/doi.org\/10.1371\/journal.pbio.0060254","journal-title":"PLoS Biol"},{"issue":"80","key":"1448_CR104","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1126\/science.1142179","volume":"317","author":"A Taguchi","year":"2007","unstructured":"Taguchi A, Wartschow LM, White MF (2007) Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 317(80):369\u2013372. \n                    https:\/\/doi.org\/10.1126\/science.1142179","journal-title":"Science"},{"key":"1448_CR105","doi-asserted-by":"publisher","first-page":"e26891","DOI":"10.1371\/journal.pone.0026891","volume":"6","author":"AF Bokov","year":"2011","unstructured":"Bokov AF, Garg N, Ikeno Y et al (2011) Does reduced IGF-1R signaling in Igf1r+\/- mice alter aging? PLoS One 6:e26891. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0026891","journal-title":"PLoS One"},{"key":"1448_CR106","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11357-011-9340-3","volume":"35","author":"J Deelen","year":"2013","unstructured":"Deelen J, Uh H-W, Monajemi R et al (2013) Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin\/IGF-1 signaling and telomere maintenance pathways. Age (Dordr) 35:235\u2013249. \n                    https:\/\/doi.org\/10.1007\/s11357-011-9340-3","journal-title":"Age (Dordr)"},{"key":"1448_CR107","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1073\/pnas.0705467105","volume":"105","author":"Y Suh","year":"2008","unstructured":"Suh Y, Atzmon G, Cho M-O et al (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A 105:3438\u20133442. \n                    https:\/\/doi.org\/10.1073\/pnas.0705467105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1448_CR108","first-page":"96","volume":"28","author":"GP Ceda","year":"2005","unstructured":"Ceda GP, Dall\u2019Aglio E, Maggio M et al (2005) Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J Endocrinol Investig 28:96\u2013100","journal-title":"J Endocrinol Investig"},{"key":"1448_CR109","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neurobiolaging.2005.10.012","volume":"28","author":"O Okereke","year":"2007","unstructured":"Okereke O, Kang JH, Ma J et al (2007) Plasma IGF-I levels and cognitive performance in older women. Neurobiol Aging 28:135\u2013142. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.10.012","journal-title":"Neurobiol Aging"},{"key":"1448_CR110","doi-asserted-by":"publisher","first-page":"e1259709","DOI":"10.1080\/23262133.2016.1259709","volume":"4","author":"GR Morel","year":"2017","unstructured":"Morel GR, Le\u00f3n ML, Uriarte M et al (2017) Therapeutic potential of IGF-I on hippocampal neurogenesis and function during aging. Neurogenesis 4:e1259709. \n                    https:\/\/doi.org\/10.1080\/23262133.2016.1259709","journal-title":"Neurogenesis"},{"key":"1448_CR111","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/gerona\/glx125","volume":"73","author":"J Pardo","year":"2018","unstructured":"Pardo J, Abba MC, Lacunza E et al (2018) IGF-I gene therapy in aging rats modulates hippocampal genes relevant to memory function. J Gerontol A Biol Sci Med Sci 73:459\u2013467. \n                    https:\/\/doi.org\/10.1093\/gerona\/glx125","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1448_CR112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2044-5040-2-15","volume":"2","author":"C Bernacchioni","year":"2012","unstructured":"Bernacchioni C, Cencetti F, Blescia S et al (2012) Sphingosine kinase\/sphingosine 1-phosphate axis: a new player for insulin-like growth factor-1-induced myoblast differentiation. Skelet Muscle 2:15. \n                    https:\/\/doi.org\/10.1186\/2044-5040-2-15","journal-title":"Skelet Muscle"},{"key":"1448_CR113","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.exphem.2011.02.013","volume":"39","author":"G Marfe","year":"2011","unstructured":"Marfe G, Di Stefano C, Gambacurta A et al (2011) Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells. Exp Hematol 39:653\u2013665.e6. \n                    https:\/\/doi.org\/10.1016\/j.exphem.2011.02.013","journal-title":"Exp Hematol"},{"key":"1448_CR114","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.4049\/jimmunol.1402304","volume":"194","author":"KJ Till","year":"2015","unstructured":"Till KJ, Pettitt AR, Slupsky JR (2015) Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase \u03b4 but not SYK or BTK in chronic lymphocytic leukemia cells. J Immunol 194:2439\u20132446. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1402304","journal-title":"J Immunol"},{"key":"1448_CR115","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1074\/jbc.M808934200","volume":"284","author":"P Giussani","year":"2009","unstructured":"Giussani P, Brioschi L, Bassi R et al (2009) Phosphatidylinositol 3-kinase\/AKT pathway regulates the endoplasmic reticulum to golgi traffic of ceramide in glioma cells: a link between lipid signaling pathways involved in the control of cell survival. J Biol Chem 284:5088\u20135096. \n                    https:\/\/doi.org\/10.1074\/jbc.M808934200","journal-title":"J Biol Chem"},{"key":"1448_CR116","doi-asserted-by":"publisher","first-page":"35622","DOI":"10.1074\/jbc.M105673200","volume":"276","author":"Y Banno","year":"2001","unstructured":"Banno Y, Takuwa Y, Akao Y et al (2001) Involvement of phospholipase D in sphingosine 1-phosphate-induced activation of phosphatidylinositol 3-kinase and Akt in Chinese hamster ovary cells overexpressing EDG3. J Biol Chem 276:35622\u201335628. \n                    https:\/\/doi.org\/10.1074\/jbc.M105673200","journal-title":"J Biol Chem"},{"key":"1448_CR117","doi-asserted-by":"publisher","first-page":"37323","DOI":"10.1074\/jbc.M202798200","volume":"277","author":"J Davaille","year":"2002","unstructured":"Davaille J, Li L, Mallat A, Lotersztajn S (2002) Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem 277:37323\u201337330. \n                    https:\/\/doi.org\/10.1074\/jbc.M202798200","journal-title":"J Biol Chem"},{"key":"1448_CR118","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jaci.2013.07.026","volume":"132","author":"H Cui","year":"2013","unstructured":"Cui H, Okamoto Y, Yoshioka K et al (2013) Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice. J Allergy Clin Immunol 132:1205\u20131214.e9. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2013.07.026","journal-title":"J Allergy Clin Immunol"},{"key":"1448_CR119","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/mcne.1999.0813","volume":"15","author":"M Salinas","year":"2000","unstructured":"Salinas M, L\u00f3pez-Valdaliso R, Mart\u00edn D et al (2000) Inhibition of PKB\/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol Cell Neurosci 15:156\u2013169. \n                    https:\/\/doi.org\/10.1006\/mcne.1999.0813","journal-title":"Mol Cell Neurosci"},{"key":"1448_CR120","doi-asserted-by":"publisher","first-page":"13620","DOI":"10.1074\/jbc.M111.304857","volume":"287","author":"J Qin","year":"2012","unstructured":"Qin J, Berdyshev E, Poirer C et al (2012) Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt. J Biol Chem 287:13620\u201313632. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.304857","journal-title":"J Biol Chem"},{"key":"1448_CR121","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1016\/j.febslet.2005.05.067","volume":"579","author":"A G\u00f3mez-Mu\u00f1oz","year":"2005","unstructured":"G\u00f3mez-Mu\u00f1oz A, Kong JY, Parhar K et al (2005) Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase\/protein kinase B pathway. FEBS Lett 579:3744\u20133750. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2005.05.067","journal-title":"FEBS Lett"},{"key":"1448_CR122","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.cellsig.2007.12.008","volume":"20","author":"P Gangoiti","year":"2008","unstructured":"Gangoiti P, Granado MH, Wang SW et al (2008) Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase\/PKB, JNK and ERK1\/2 pathways. Cell Signal 20:726\u2013736. \n                    https:\/\/doi.org\/10.1016\/j.cellsig.2007.12.008","journal-title":"Cell Signal"},{"key":"1448_CR123","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1476-5381.2010.01053.x","volume":"162","author":"A Huwiler","year":"2011","unstructured":"Huwiler A, Kotelevets N, Xin C et al (2011) Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage. Br J Pharmacol 162:532\u2013543. \n                    https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01053.x","journal-title":"Br J Pharmacol"},{"key":"1448_CR124","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1172\/JCI1180","volume":"102","author":"GS Dbaibo","year":"1998","unstructured":"Dbaibo GS, Pushkareva MY, Rachid RA et al (1998) p53-dependent ceramide response to genotoxic stress. J Clin Invest 102:329\u2013339. \n                    https:\/\/doi.org\/10.1172\/JCI1180","journal-title":"J Clin Invest"},{"key":"1448_CR125","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.10312","volume":"52","author":"RG Cutler","year":"2002","unstructured":"Cutler RG, Pedersen WA, Camandola S et al (2002) Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol 52:448\u2013457. \n                    https:\/\/doi.org\/10.1002\/ana.10312","journal-title":"Ann Neurol"},{"key":"1448_CR126","doi-asserted-by":"publisher","first-page":"16281","DOI":"10.1074\/jbc.272.26.16281","volume":"272","author":"B Liu","year":"1997","unstructured":"Liu B, Hannun YA (1997) Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J Biol Chem 272:16281\u201316287","journal-title":"J Biol Chem"},{"key":"1448_CR127","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neulet.2012.04.019","volume":"516","author":"M Kosicek","year":"2012","unstructured":"Kosicek M, Zetterberg H, Andreasen N et al (2012) Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer\u2019s disease. Neurosci Lett 516:302\u2013305. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2012.04.019","journal-title":"Neurosci Lett"},{"key":"1448_CR128","doi-asserted-by":"publisher","first-page":"170069","DOI":"10.1098\/rsob.170069","volume":"7","author":"ASB Olsen","year":"2017","unstructured":"Olsen ASB, F\u00e6rgeman NJ (2017) Sphingolipids: membrane microdomains in brain development, function and neurological diseases. Open Biol 7:170069. \n                    https:\/\/doi.org\/10.1098\/rsob.170069","journal-title":"Open Biol"},{"issue":"Suppl 1","key":"1448_CR129","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1111\/j.1447-0594.2010.00600.x","volume":"10","author":"Y Ohno-Iwashita","year":"2010","unstructured":"Ohno-Iwashita Y, Shimada Y, Hayashi M, Inomata M (2010) Plasma membrane microdomains in aging and disease. Geriatr Gerontol Int 10(Suppl 1):S41\u2013S52. \n                    https:\/\/doi.org\/10.1111\/j.1447-0594.2010.00600.x","journal-title":"Geriatr Gerontol Int"},{"key":"1448_CR130","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.1074\/jbc.RA118.001986","volume":"293","author":"SMM Badawy","year":"2018","unstructured":"Badawy SMM, Okada T, Kajimoto T et al (2018) Extracellular \u03b1-synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling. J Biol Chem 293:8208\u20138216. \n                    https:\/\/doi.org\/10.1074\/jbc.RA118.001986","journal-title":"J Biol Chem"},{"key":"1448_CR131","doi-asserted-by":"publisher","first-page":"695413","DOI":"10.4061\/2011\/695413","volume":"2011","author":"MOW Grimm","year":"2011","unstructured":"Grimm MOW, Gr\u00f6sgen S, Rothhaar TL et al (2011) Intracellular APP domain regulates serine-palmitoyl-CoA transferase expression and is affected in Alzheimer\u2019s disease. Int J Alzheimers Dis 2011:695413. \n                    https:\/\/doi.org\/10.4061\/2011\/695413","journal-title":"Int J Alzheimers Dis"},{"key":"1448_CR132","doi-asserted-by":"publisher","first-page":"20868","DOI":"10.1074\/jbc.M112.445734","volume":"288","author":"MS Kang","year":"2013","unstructured":"Kang MS, Baek S-H, Chun YS et al (2013) Modulation of lipid kinase PI4KII\u03b1 activity and lipid raft association of presenilin 1 underlies \u03b3-secretase inhibition by ginsenoside (20S)-Rg3. J Biol Chem 288:20868\u201320882. \n                    https:\/\/doi.org\/10.1074\/jbc.M112.445734","journal-title":"J Biol Chem"},{"key":"1448_CR133","doi-asserted-by":"publisher","first-page":"9411","DOI":"10.1002\/anie.201603178","volume":"55","author":"M Amaro","year":"2016","unstructured":"Amaro M, \u0160achl R, Aydogan G et al (2016) GM1 ganglioside inhibits \u03b2-amyloid oligomerization induced by sphingomyelin. Angew Chem Int Ed Engl 55:9411\u20139415. \n                    https:\/\/doi.org\/10.1002\/anie.201603178","journal-title":"Angew Chem Int Ed Engl"},{"key":"1448_CR134","doi-asserted-by":"publisher","first-page":"20997","DOI":"10.1038\/srep20997","volume":"6","author":"V Rondelli","year":"2016","unstructured":"Rondelli V, Brocca P, Motta S et al (2016) Amyloid-\u03b2 peptides in interaction with raft-mime model membranes: a neutron reflectivity insight. Sci Rep 6:20997. \n                    https:\/\/doi.org\/10.1038\/srep20997","journal-title":"Sci Rep"},{"key":"1448_CR135","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.bbamem.2009.01.012","volume":"1788","author":"I Peters","year":"2009","unstructured":"Peters I, Igbavboa U, Sch\u00fctt T et al (2009) The interaction of beta-amyloid protein with cellular membranes stimulates its own production. Biochim Biophys Acta 1788:964\u2013972. \n                    https:\/\/doi.org\/10.1016\/j.bbamem.2009.01.012","journal-title":"Biochim Biophys Acta"},{"key":"1448_CR136","doi-asserted-by":"publisher","first-page":"11984","DOI":"10.1074\/jbc.M309832200","volume":"279","author":"N Sawamura","year":"2004","unstructured":"Sawamura N, Ko M, Yu W et al (2004) Modulation of amyloid precursor protein cleavage by cellular sphingolipids. J Biol Chem 279:11984\u201311991. \n                    https:\/\/doi.org\/10.1074\/jbc.M309832200","journal-title":"J Biol Chem"},{"key":"1448_CR137","doi-asserted-by":"publisher","first-page":"19777","DOI":"10.1074\/jbc.M300466200","volume":"278","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Ellis BC, Saunders AJ, Kovacs DM (2003) Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis. J Biol Chem 278:19777\u201319783. \n                    https:\/\/doi.org\/10.1074\/jbc.M300466200","journal-title":"J Biol Chem"},{"key":"1448_CR138","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbrc.2014.12.087","volume":"457","author":"N Takasugi","year":"2015","unstructured":"Takasugi N, Sasaki T, Shinohara M et al (2015) Synthetic ceramide analogues increase amyloid-\u03b2 42 production by modulating \u03b3-secretase activity. Biochem Biophys Res Commun 457:194\u2013199. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2014.12.087","journal-title":"Biochem Biophys Res Commun"},{"key":"1448_CR139","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s12031-013-9979-6","volume":"50","author":"M Asle-Rousta","year":"2013","unstructured":"Asle-Rousta M, Kolahdooz Z, Oryan S et al (2013) FTY720 (fingolimod) attenuates beta-amyloid peptide (A\u03b242)-induced impairment of spatial learning and memory in rats. J Mol Neurosci 50:524\u2013532. \n                    https:\/\/doi.org\/10.1007\/s12031-013-9979-6","journal-title":"J Mol Neurosci"},{"key":"1448_CR140","doi-asserted-by":"publisher","first-page":"41734","DOI":"10.1038\/srep41734","volume":"7","author":"P Joshi","year":"2017","unstructured":"Joshi P, Gabrielli M, Ponzoni L et al (2017) Fingolimod limits acute A\u03b2 neurotoxicity and promotes synaptic versus extrasynaptic NMDA receptor functionality in hippocampal neurons. Sci Rep 7:41734. \n                    https:\/\/doi.org\/10.1038\/srep41734","journal-title":"Sci Rep"},{"key":"1448_CR141","doi-asserted-by":"publisher","first-page":"e64050","DOI":"10.1371\/journal.pone.0064050","volume":"8","author":"N Takasugi","year":"2013","unstructured":"Takasugi N, Sasaki T, Ebinuma I et al (2013) FTY720\/fingolimod, a sphingosine analogue, reduces amyloid-\u03b2 production in neurons. PLoS One 8:e64050. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0064050","journal-title":"PLoS One"},{"key":"1448_CR142","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1523\/JNEUROSCI.6467-10.2011","volume":"31","author":"N Takasugi","year":"2011","unstructured":"Takasugi N, Sasaki T, Suzuki K et al (2011) BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. J Neurosci 31:6850\u20136857. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.6467-10.2011","journal-title":"J Neurosci"},{"key":"1448_CR143","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-018-0527-z","volume":"6","author":"G Dominguez","year":"2018","unstructured":"Dominguez G, Maddelein M-L, Pucelle M et al (2018) Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer\u2019s disease brain. Acta Neuropathol Commun 6:25. \n                    https:\/\/doi.org\/10.1186\/s40478-018-0527-z","journal-title":"Acta Neuropathol Commun"},{"key":"1448_CR144","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2051-5960-2-12","volume":"2","author":"J Ceccom","year":"2014","unstructured":"Ceccom J, Loukh N, Lauwers-Cances V et al (2014) Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer\u2019s disease. Acta Neuropathol Commun 2:12. \n                    https:\/\/doi.org\/10.1186\/2051-5960-2-12","journal-title":"Acta Neuropathol Commun"},{"key":"1448_CR145","doi-asserted-by":"publisher","first-page":"16761","DOI":"10.1074\/jbc.M113.535500","volume":"289","author":"I Karaca","year":"2014","unstructured":"Karaca I, Tamboli IY, Glebov K et al (2014) Deficiency of sphingosine-1-phosphate lyase impairs lysosomal metabolism of the amyloid precursor protein. J Biol Chem 289:16761\u201316772. \n                    https:\/\/doi.org\/10.1074\/jbc.M113.535500","journal-title":"J Biol Chem"},{"key":"1448_CR146","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5114\/fn.2014.41745","volume":"52","author":"H Jesko","year":"2014","unstructured":"Jesko H, Okada T, Strosznajder RP, Nakamura S (2014) Sphingosine kinases modulate the secretion of amyloid \u03b2 precursor protein from SH-SY5Y neuroblastoma cells: the role of \u03b1-synuclein. Folia Neuropathol 52:70\u201378","journal-title":"Folia Neuropathol"},{"key":"1448_CR147","doi-asserted-by":"publisher","unstructured":"J\u0119\u015bko H, Wencel PL, Lukiw WJ, Strosznajder RP (2018) Modulatory effects of fingolimod (FTY720) on the expression of sphingolipid metabolism-related genes in an animal model of Alzheimer\u2019s disease. Mol Neurobiol \n                    https:\/\/doi.org\/10.1007\/s12035-018-1040-x","DOI":"10.1007\/s12035-018-1040-x"},{"key":"1448_CR148","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K et al (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 101:2070\u20132075. \n                    https:\/\/doi.org\/10.1073\/pnas.0305799101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1448_CR149","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","volume":"32","author":"P Katsel","year":"2007","unstructured":"Katsel P, Li C, Haroutunian V (2007) Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer\u2019s disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer\u2019s disease? Neurochem Res 32:845\u2013856. \n                    https:\/\/doi.org\/10.1007\/s11064-007-9297-x","journal-title":"Neurochem Res"},{"key":"1448_CR150","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2010","unstructured":"He X, Huang Y, Li B et al (2010) Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease. Neurobiol Aging 31:398\u2013408. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.05.010","journal-title":"Neurobiol Aging"},{"key":"1448_CR151","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.neurobiolaging.2007.07.024","volume":"30","author":"VVR Bandaru","year":"2009","unstructured":"Bandaru VVR, Troncoso J, Wheeler D et al (2009) ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer\u2019s but not normal brain. Neurobiol Aging 30:591\u2013599. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.07.024","journal-title":"Neurobiol Aging"},{"key":"1448_CR152","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200307017","volume":"164","author":"J-T Lee","year":"2004","unstructured":"Lee J-T, Xu J, Lee J-M et al (2004) Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 164:123\u2013131. \n                    https:\/\/doi.org\/10.1083\/jcb.200307017","journal-title":"J Cell Biol"},{"key":"1448_CR153","doi-asserted-by":"publisher","first-page":"51451","DOI":"10.1074\/jbc.M404635200","volume":"279","author":"A Jana","year":"2004","unstructured":"Jana A, Pahan K (2004) Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer\u2019s disease J Biol Chem 279:51451\u201351459. \n                    https:\/\/doi.org\/10.1074\/jbc.M404635200","journal-title":"Implications for Alzheimer\u2019s disease J Biol Chem"},{"key":"1448_CR154","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1124\/mol.106.033738","volume":"72","author":"A Gomez-Brouchet","year":"2007","unstructured":"Gomez-Brouchet A, Pchejetski D, Brizuela L et al (2007) Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-beta peptide. Mol Pharmacol 72:341\u2013349. \n                    https:\/\/doi.org\/10.1124\/mol.106.033738","journal-title":"Mol Pharmacol"},{"key":"1448_CR155","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.freeradbiomed.2004.04.007","volume":"37","author":"K Ayasolla","year":"2004","unstructured":"Ayasolla K, Khan M, Singh AK, Singh I (2004) Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic Biol Med 37:325\u2013338. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.04.007","journal-title":"Free Radic Biol Med"},{"key":"1448_CR156","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1471-4159.2005.03217.x","volume":"94","author":"C Zeng","year":"2005","unstructured":"Zeng C, Lee JT, Chen H et al (2005) Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase\/ceramide pathway in oligodendrocytes. J Neurochem 94:703\u2013712. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03217.x","journal-title":"J Neurochem"},{"key":"1448_CR157","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1326-7-45","volume":"7","author":"TN Martinez","year":"2012","unstructured":"Martinez TN, Chen X, Bandyopadhyay S et al (2012) Ceramide sphingolipid signaling mediates tumor necrosis factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons. Mol Neurodegener 7:45. \n                    https:\/\/doi.org\/10.1186\/1750-1326-7-45","journal-title":"Mol Neurodegener"},{"key":"1448_CR158","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1000\/182","volume":"32","author":"AV Alessenko","year":"2004","unstructured":"Alessenko AV, Bugrova AE, Dudnik LB (2004) Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer\u2019s disease. Biochem Soc Trans 32:144\u2013146. \n                    https:\/\/doi.org\/10.1000\/182","journal-title":"Biochem Soc Trans"},{"key":"1448_CR159","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ncb1313","volume":"7","author":"MOW Grimm","year":"2005","unstructured":"Grimm MOW, Grimm HS, P\u00e4tzold AJ et al (2005) Regulation of cholesterol and sphingomyelin metabolism by amyloid-\u03b2 and presenilin. Nat Cell Biol 7:1118\u20131123. \n                    https:\/\/doi.org\/10.1038\/ncb1313","journal-title":"Nat Cell Biol"},{"key":"1448_CR160","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1523\/JNEUROSCI.1429-16.2016","volume":"36","author":"MB Dinkins","year":"2016","unstructured":"Dinkins MB, Enasko J, Hernandez C et al (2016) Neutral sphingomyelinase-2 deficiency ameliorates Alzheimer\u2019s disease pathology and improves cognition in the 5XFAD mouse. J Neurosci 36:8653\u20138667. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1429-16.2016","journal-title":"J Neurosci"},{"key":"1448_CR161","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.neurobiolaging.2013.02.001","volume":"34","author":"H Geekiyanage","year":"2013","unstructured":"Geekiyanage H, Upadhye A, Chan C (2013) Inhibition of serine palmitoyltransferase reduces A\u03b2 and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer\u2019s disease. Neurobiol Aging 34:2037\u20132051. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.02.001","journal-title":"Neurobiol Aging"},{"key":"1448_CR162","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nbd.2014.01.010","volume":"65","author":"M Panchal","year":"2014","unstructured":"Panchal M, Gaudin M, Lazar AN et al (2014) Ceramides and sphingomyelinases in senile plaques. Neurobiol Dis 65:193\u2013201. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2014.01.010","journal-title":"Neurobiol Dis"},{"key":"1448_CR163","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11064-014-1240-3","volume":"39","author":"M Gassowska","year":"2014","unstructured":"Gassowska M, Cieslik M, Wilkaniec A, Strosznajder JB (2014) Sphingosine kinases\/sphingosine-1-phosphate and death Signalling in APP-transfected cells. Neurochem Res 39:645\u2013652. \n                    https:\/\/doi.org\/10.1007\/s11064-014-1240-3","journal-title":"Neurochem Res"},{"key":"1448_CR164","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1212\/WNL.0000000000001491","volume":"84","author":"J Kuhle","year":"2015","unstructured":"Kuhle J, Disanto G, Lorscheider J et al (2015) Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis. Neurology 84:1639\u20131643. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000001491","journal-title":"Neurology"},{"key":"1448_CR165","doi-asserted-by":"publisher","first-page":"14196","DOI":"10.1073\/pnas.95.24.14196","volume":"95","author":"P Xia","year":"1998","unstructured":"Xia P, Gamble JR, Rye KA et al (1998) Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci U S A 95:14196\u201314201","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1448_CR166","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1096\/fj.03-1050fje","volume":"18","author":"NC Kaneider","year":"2004","unstructured":"Kaneider NC, Lindner J, Feistritzer C et al (2004) The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor. FASEB J 18:1309\u20131311. \n                    https:\/\/doi.org\/10.1096\/fj.03-1050fje","journal-title":"FASEB J"},{"key":"1448_CR167","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3233\/JAD-150088","volume":"46","author":"MB Dinkins","year":"2015","unstructured":"Dinkins MB, Dasgupta S, Wang G et al (2015) The 5XFAD mouse model of Alzheimer\u2019s disease exhibits an age-dependent increase in anti-ceramide IgG and exogenous administration of ceramide further increases anti-ceramide titers and amyloid plaque burden. J Alzheimers Dis 46:55\u201361. \n                    https:\/\/doi.org\/10.3233\/JAD-150088","journal-title":"J Alzheimers Dis"},{"key":"1448_CR168","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H et al (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106\u2013118. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"key":"1448_CR169","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1074\/jbc.M114.596445","volume":"290","author":"M Kurano","year":"2015","unstructured":"Kurano M, Tsukamoto K, Hara M et al (2015) LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate. J Biol Chem 290:2477\u20132488. \n                    https:\/\/doi.org\/10.1074\/jbc.M114.596445","journal-title":"J Biol Chem"},{"key":"1448_CR170","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.bbalip.2010.01.010","volume":"1801","author":"X Han","year":"2010","unstructured":"Han X (2010) Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer\u2019s disease. Biochim Biophys Acta 1801:774\u2013783. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2010.01.010","journal-title":"Biochim Biophys Acta"},{"key":"1448_CR171","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.bbagen.2016.03.009","volume":"1860","author":"ST Gizaw","year":"2016","unstructured":"Gizaw ST, Ohashi T, Tanaka M et al (2016) Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer\u2019s disease brain, serum and cerebrospinal fluid towards potential biomarker discovery. Biochim Biophys Acta 1860:1716\u20131727. \n                    https:\/\/doi.org\/10.1016\/j.bbagen.2016.03.009","journal-title":"Biochim Biophys Acta"},{"key":"1448_CR172","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12017-010-8121-y","volume":"12","author":"MM Mielke","year":"2010","unstructured":"Mielke MM, Lyketsos CG (2010) Alterations of the sphingolipid pathway in Alzheimer\u2019s disease: new biomarkers and treatment targets? NeuroMolecular Med 12:331\u2013340. \n                    https:\/\/doi.org\/10.1007\/s12017-010-8121-y","journal-title":"NeuroMolecular Med"},{"key":"1448_CR173","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbalip.2013.08.002","volume":"1841","author":"K Yuyama","year":"2014","unstructured":"Yuyama K, Mitsutake S, Igarashi Y (2014) Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer\u2019s disease. Biochim Biophys Acta 1841:793\u2013798. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2013.08.002","journal-title":"Biochim Biophys Acta"},{"key":"1448_CR174","doi-asserted-by":"publisher","first-page":"21384","DOI":"10.1074\/jbc.M112.340513","volume":"287","author":"G Wang","year":"2012","unstructured":"Wang G, Dinkins M, He Q et al (2012) Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 287:21384\u201321395. \n                    https:\/\/doi.org\/10.1074\/jbc.M112.340513","journal-title":"J Biol Chem"},{"key":"1448_CR175","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1096\/fj.07-9357.com","volume":"22","author":"RA Sharples","year":"2008","unstructured":"Sharples RA, Vella LJ, Nisbet RM et al (2008) Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. FASEB J 22:1469\u20131478. \n                    https:\/\/doi.org\/10.1096\/fj.07-9357.com","journal-title":"FASEB J"},{"key":"1448_CR176","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"L Rajendran","year":"2006","unstructured":"Rajendran L, Honsho M, Zahn TR et al (2006) Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci 103:11172\u201311177. \n                    https:\/\/doi.org\/10.1073\/pnas.0603838103","journal-title":"Proc Natl Acad Sci"},{"key":"1448_CR177","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3233\/JAD-160567","volume":"60","author":"MB Dinkins","year":"2017","unstructured":"Dinkins MB, Wang G, Bieberich E (2017) Sphingolipid-enriched extracellular vesicles and Alzheimer\u2019s disease: a decade of research. J Alzheimers Dis 60:757\u2013768. \n                    https:\/\/doi.org\/10.3233\/JAD-160567","journal-title":"J Alzheimers Dis"},{"key":"1448_CR178","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1074\/jbc.M111.324616","volume":"287","author":"K Yuyama","year":"2012","unstructured":"Yuyama K, Sun H, Mitsutake S, Igarashi Y (2012) Sphingolipid-modulated exosome secretion promotes clearance of amyloid-\u03b2 by microglia. J Biol Chem 287:10977\u201310989. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.324616","journal-title":"J Biol Chem"},{"key":"1448_CR179","doi-asserted-by":"publisher","unstructured":"Yuyama K, Igarashi Y (2017) Exosomes as carriers of Alzheimer\u2019s amyloid-\u00df. Front Neurosci 11(229). \n                    https:\/\/doi.org\/10.3389\/fnins.2017.00229","DOI":"10.3389\/fnins.2017.00229"},{"key":"1448_CR180","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-017-0445-5","volume":"5","author":"J Ngolab","year":"2017","unstructured":"Ngolab J, Trinh I, Rockenstein E et al (2017) Brain-derived exosomes from dementia with Lewy bodies propagate \u03b1-synuclein pathology. Acta Neuropathol Commun 5:46. \n                    https:\/\/doi.org\/10.1186\/s40478-017-0445-5","journal-title":"Acta Neuropathol Commun"},{"key":"1448_CR181","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang Y, Balaji V, Kaniyappan S et al (2017) The release and trans-synaptic transmission of tau via exosomes. Mol Neurodegener 12:5. \n                    https:\/\/doi.org\/10.1186\/s13024-016-0143-y","journal-title":"Mol Neurodegener"},{"key":"1448_CR182","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1074\/jbc.M117.808733","volume":"293","author":"T Kajimoto","year":"2018","unstructured":"Kajimoto T, Mohamed NNI, Badawy SMM et al (2018) Involvement of G\u03b2\u03b3 subunits of Gi protein coupled with S1P receptor on multivesicular endosomes in F-actin formation and cargo sorting into exosomes. J Biol Chem 293:245\u2013253. \n                    https:\/\/doi.org\/10.1074\/jbc.M117.808733","journal-title":"J Biol Chem"},{"key":"1448_CR183","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","volume":"35","author":"MB Dinkins","year":"2014","unstructured":"Dinkins MB, Dasgupta S, Wang G et al (2014) Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging 35:1792\u20131800. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.02.012","journal-title":"Neurobiol Aging"},{"key":"1448_CR184","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF03033777","volume":"7","author":"M Broe","year":"2005","unstructured":"Broe M, Shepherd CE, Mann DMA et al (2005) Insoluble alpha-synuclein in Alzheimer\u2019s disease without Lewy body formation. Neurotox Res 7:69\u201376","journal-title":"Neurotox Res"},{"key":"1448_CR185","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/bpa.12373","volume":"26","author":"E Emmanouilidou","year":"2016","unstructured":"Emmanouilidou E, Vekrellis K (2016) Exocytosis and spreading of normal and aberrant \u03b1-synuclein. Brain Pathol 26:398\u2013403. \n                    https:\/\/doi.org\/10.1111\/bpa.12373","journal-title":"Brain Pathol"},{"key":"1448_CR186","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12974-016-0519-5","volume":"13","author":"DP Christensen","year":"2016","unstructured":"Christensen DP, Ejlerskov P, Rasmussen I, Vilhardt F (2016) Reciprocal signals between microglia and neurons regulate \u03b1-synuclein secretion by exophagy through a neuronal cJUN-N-terminal kinase-signaling axis. J Neuroinflammation 13:59. \n                    https:\/\/doi.org\/10.1186\/s12974-016-0519-5","journal-title":"J Neuroinflammation"},{"key":"1448_CR187","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/jnc.12131","volume":"125","author":"S Paillusson","year":"2013","unstructured":"Paillusson S, Clairembault T, Biraud M et al (2013) Activity-dependent secretion of alpha-synuclein by enteric neurons. J Neurochem 125:512\u2013517. \n                    https:\/\/doi.org\/10.1111\/jnc.12131","journal-title":"J Neurochem"},{"key":"1448_CR188","doi-asserted-by":"publisher","first-page":"17313","DOI":"10.1074\/jbc.M112.401174","volume":"288","author":"P Ejlerskov","year":"2013","unstructured":"Ejlerskov P, Rasmussen I, Nielsen TT et al (2013) Tubulin polymerization-promoting protein (TPPP\/p25\u03b1) promotes unconventional secretion of \u03b1-synuclein through exophagy by impairing autophagosome-lysosome fusion. J Biol Chem 288:17313\u201317335. \n                    https:\/\/doi.org\/10.1074\/jbc.M112.401174","journal-title":"J Biol Chem"},{"key":"1448_CR189","doi-asserted-by":"publisher","first-page":"e29460","DOI":"10.1371\/journal.pone.0029460","volume":"6","author":"T Hasegawa","year":"2011","unstructured":"Hasegawa T, Konno M, Baba T et al (2011) The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of \u03b1-synuclein. PLoS One 6:e29460. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0029460","journal-title":"PLoS One"},{"key":"1448_CR190","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/hmg\/ddy075","volume":"27","author":"VE Papadopoulos","year":"2018","unstructured":"Papadopoulos VE, Nikolopoulou G, Antoniadou I et al (2018) Modulation of \u03b2-glucocerebrosidase increases \u03b1-synuclein secretion and exosome release in mouse models of Parkinson\u2019s disease. Hum Mol Genet 27:1696\u20131710. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddy075","journal-title":"Hum Mol Genet"},{"key":"1448_CR191","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2017.09.016","volume":"61","author":"S Zhang","year":"2018","unstructured":"Zhang S, Eitan E, Wu T-Y, Mattson MP (2018) Intercellular transfer of pathogenic \u03b1-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal. Neurobiol Aging 61:52\u201365. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.09.016","journal-title":"Neurobiol Aging"},{"key":"1448_CR192","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/mds.25729","volume":"29","author":"SK Abbott","year":"2014","unstructured":"Abbott SK, Li H, Mu\u00f1oz SS et al (2014) Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson\u2019s disease. Mov Disord 29:518\u2013526","journal-title":"Mov Disord"},{"key":"1448_CR193","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.neuroscience.2015.01.032","volume":"290","author":"M Sivasubramanian","year":"2015","unstructured":"Sivasubramanian M, Kanagaraj N, Dheen ST, Tay SSW (2015) Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson\u2019s disease and in MPP+-treated MN9D cells in vitro. Neuroscience 290:636\u2013648. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2015.01.032","journal-title":"Neuroscience"},{"key":"1448_CR194","doi-asserted-by":"publisher","unstructured":"Motyl J, Przykaza \u0141, Boguszewski PM, Kosson P, Strosznajder JB (2018) Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase. Neuropharmacology 135:139\u2013150. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.023","DOI":"10.1016\/j.neuropharm.2018.02.023"},{"key":"1448_CR195","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.bbrc.2016.08.082","volume":"478","author":"R Ferrazza","year":"2016","unstructured":"Ferrazza R, Cogo S, Melrose H et al (2016) LRRK2 deficiency impacts ceramide metabolism in brain. Biochem Biophys Res Commun 478:1141\u20131146. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.082","journal-title":"Biochem Biophys Res Commun"},{"key":"1448_CR196","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1111\/j.1742-4658.2008.06709.x","volume":"275","author":"J Bras","year":"2008","unstructured":"Bras J, Singleton A, Cookson MR, Hardy J (2008) Emerging pathways in genetic Parkinson\u2019s disease: potential role of ceramide metabolism in Lewy body disease. FEBS J 275:5767\u20135773. \n                    https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06709.x","journal-title":"FEBS J"},{"key":"1448_CR197","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s12640-017-9798-6","volume":"33","author":"J Brodowicz","year":"2018","unstructured":"Brodowicz J, Przegali\u0144ski E, M\u00fcller CP, Filip M (2018) Ceramide and its related neurochemical networks as targets for some brain disorder therapies. Neurotox Res 33:474\u2013484. \n                    https:\/\/doi.org\/10.1007\/s12640-017-9798-6","journal-title":"Neurotox Res"},{"key":"1448_CR198","doi-asserted-by":"publisher","first-page":"e73094","DOI":"10.1371\/journal.pone.0073094","volume":"8","author":"MM Mielke","year":"2013","unstructured":"Mielke MM, Maetzler W, Haughey NJ et al (2013) Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson\u2019s disease and associated with cognitive impairment: a pilot study. PLoS One 8:e73094. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0073094","journal-title":"PLoS One"},{"key":"1448_CR199","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2016.09.028","volume":"370","author":"Y Xing","year":"2016","unstructured":"Xing Y, Tang Y, Zhao L et al (2016) Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson\u2019s disease dementia. J Neurol Sci 370:82\u201387. \n                    https:\/\/doi.org\/10.1016\/j.jns.2016.09.028","journal-title":"J Neurol Sci"},{"key":"1448_CR200","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.parkreldis.2016.10.014","volume":"34","author":"C Mao","year":"2017","unstructured":"Mao C, Yang J, Wang H et al (2017) SMPD1 variants in Chinese Han patients with sporadic Parkinson\u2019s disease. Parkinsonism Relat Disord 34:59\u201361. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2016.10.014","journal-title":"Parkinsonism Relat Disord"},{"key":"1448_CR201","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.parkreldis.2015.08.018","volume":"21","author":"Z Gan-Or","year":"2015","unstructured":"Gan-Or Z, Orr-Urtreger A, Alcalay RN et al (2015) The emerging role of SMPD1 mutations in Parkinson\u2019s disease: implications for future studies. Parkinsonism Relat Disord 21:1294\u20131295. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2015.08.018","journal-title":"Parkinsonism Relat Disord"},{"key":"1448_CR202","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.parkreldis.2015.06.016","volume":"21","author":"E Dagan","year":"2015","unstructured":"Dagan E, Schlesinger I, Ayoub M et al (2015) The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews. Parkinsonism Relat Disord 21:1067\u20131071. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2015.06.016","journal-title":"Parkinsonism Relat Disord"},{"key":"1448_CR203","doi-asserted-by":"publisher","first-page":"2890.e13","DOI":"10.1016\/j.neurobiolaging.2013.06.010","volume":"34","author":"J-N Foo","year":"2013","unstructured":"Foo J-N, Liany H, Bei J-X et al (2013) Rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson\u2019s disease. Neurobiol Aging 34:2890.e13\u20132890.e15. \n                    https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.06.010","journal-title":"Neurobiol Aging"},{"key":"1448_CR204","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1007\/s12035-015-9426-5","volume":"53","author":"S Deng","year":"2016","unstructured":"Deng S, Deng X, Song Z et al (2016) Systematic genetic analysis of the SMPD1 gene in Chinese patients with Parkinson\u2019s disease. Mol Neurobiol 53:5025\u20135029. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9426-5","journal-title":"Mol Neurobiol"},{"key":"1448_CR205","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12035-013-8622-4","volume":"50","author":"J Pyszko","year":"2014","unstructured":"Pyszko J, Strosznajder JB (2014) Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-Phenylpyridinium (MPP+) in human dopaminergic neuronal cells. Mol Neurobiol 50:38\u201348. \n                    https:\/\/doi.org\/10.1007\/s12035-013-8622-4","journal-title":"Mol Neurobiol"},{"key":"1448_CR206","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/15548627.2017.1291471","volume":"13","author":"DN Mitroi","year":"2017","unstructured":"Mitroi DN, Karunakaran I, Gr\u00e4ler M et al (2017) SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production. Autophagy 13:885\u2013899. \n                    https:\/\/doi.org\/10.1080\/15548627.2017.1291471","journal-title":"Autophagy"},{"key":"1448_CR207","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s11064-016-2125-4","volume":"42","author":"M Ren","year":"2017","unstructured":"Ren M, Han M, Wei X et al (2017) FTY720 attenuates 6-OHDA-associated dopaminergic degeneration in cellular and mouse parkinsonian models. Neurochem Res 42:686\u2013696. \n                    https:\/\/doi.org\/10.1007\/s11064-016-2125-4","journal-title":"Neurochem Res"},{"key":"1448_CR208","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1096\/fj.201600751R","volume":"31","author":"P Zhao","year":"2017","unstructured":"Zhao P, Yang X, Yang L et al (2017) Neuroprotective effects of fingolimod in mouse models of Parkinson\u2019s disease. FASEB J 31:172\u2013179. \n                    https:\/\/doi.org\/10.1096\/fj.201600751R","journal-title":"FASEB J"},{"key":"1448_CR209","doi-asserted-by":"publisher","unstructured":"Komnig D, Dagli CT, Habib P, et al (2018) Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson disease and does not lead to a sustainable increase of brain BDNF. J Neurochem \n                    https:\/\/doi.org\/10.1111\/jnc.14575","DOI":"10.1111\/jnc.14575"},{"key":"1448_CR210","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3233\/JPD-2012-11059","volume":"2","author":"WS Kim","year":"2012","unstructured":"Kim WS, Halliday GM (2012) Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression. J Parkinsons Dis 2:41\u201346. \n                    https:\/\/doi.org\/10.3233\/JPD-2012-11059","journal-title":"J Parkinsons Dis"},{"key":"1448_CR211","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.pharep.2015.12.008","volume":"68","author":"K Bienias","year":"2016","unstructured":"Bienias K, Fiedorowicz A, Sadowska A et al (2016) Regulation of sphingomyelin metabolism. Pharmacol Rep 68:570\u2013581. \n                    https:\/\/doi.org\/10.1016\/j.pharep.2015.12.008","journal-title":"Pharmacol Rep"},{"key":"1448_CR212","doi-asserted-by":"publisher","first-page":"20811","DOI":"10.1074\/jbc.M116.744029","volume":"291","author":"G Vidal-Mart\u00ednez","year":"2016","unstructured":"Vidal-Mart\u00ednez G, Vargas-Medrano J, Gil-Tommee C et al (2016) FTY720\/fingolimod reduces synucleinopathy and improves gut motility in A53T mice: contributions of pro-brain-derived neurotrophic factor (PRO-BDNF) and mature BDNF. J Biol Chem 291:20811\u201320821. \n                    https:\/\/doi.org\/10.1074\/jbc.M116.744029","journal-title":"J Biol Chem"},{"key":"1448_CR213","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00702-017-1779-7","volume":"124","author":"S Sato","year":"2017","unstructured":"Sato S, Li Y, Hattori N (2017) Lysosomal defects in ATP13A2 and GBA associated familial Parkinson\u2019s disease. J Neural Transm 124:1395\u20131400. \n                    https:\/\/doi.org\/10.1007\/s00702-017-1779-7","journal-title":"J Neural Transm"},{"key":"1448_CR214","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neulet.2016.10.039","volume":"636","author":"S Pchelina","year":"2017","unstructured":"Pchelina S, Emelyanov A, Baydakova G et al (2017) Oligomeric \u03b1-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson\u2019s disease. Neurosci Lett 636:70\u201376. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2016.10.039","journal-title":"Neurosci Lett"},{"key":"1448_CR215","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2018.03.017","volume":"674","author":"H Jin","year":"2018","unstructured":"Jin H, Chen J, Li K et al (2018) A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson\u2019s disease in Han Chinese patients. Neurosci Lett 674:66\u201369. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2018.03.017","journal-title":"Neurosci Lett"},{"key":"1448_CR216","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bcmd.2016.11.007","volume":"68","author":"D Arkadir","year":"2018","unstructured":"Arkadir D, Dinur T, Mullin S et al (2018) Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutations. Blood Cells Mol Dis 68:115\u2013116. \n                    https:\/\/doi.org\/10.1016\/j.bcmd.2016.11.007","journal-title":"Blood Cells Mol Dis"},{"key":"1448_CR217","doi-asserted-by":"publisher","first-page":"e0167749","DOI":"10.1371\/journal.pone.0167749","volume":"11","author":"S Jes\u00fas","year":"2016","unstructured":"Jes\u00fas S, Huertas I, Bernal-Bernal I et al (2016) GBA variants influence motor and non-motor features of Parkinson\u2019s disease. PLoS One 11:e0167749. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0167749","journal-title":"PLoS One"},{"key":"1448_CR218","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jns.2016.08.059","volume":"370","author":"M Swan","year":"2016","unstructured":"Swan M, Doan N, Ortega RA et al (2016) Neuropsychiatric characteristics of GBA-associated Parkinson disease. J Neurol Sci 370:63\u201369. \n                    https:\/\/doi.org\/10.1016\/j.jns.2016.08.059","journal-title":"J Neurol Sci"},{"key":"1448_CR219","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/mds.27136","volume":"32","author":"L Parnetti","year":"2017","unstructured":"Parnetti L, Paciotti S, Eusebi P et al (2017) Cerebrospinal fluid \u03b2-glucocerebrosidase activity is reduced in parkinson\u2019s disease patients. Mov Disord 32:1423\u20131431. \n                    https:\/\/doi.org\/10.1002\/mds.27136","journal-title":"Mov Disord"},{"key":"1448_CR220","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jalz.2018.04.006","volume":"14","author":"KA Lunde","year":"2018","unstructured":"Lunde KA, Chung J, Dalen I et al (2018) Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson\u2019s disease. Alzheimers Dement 14:1293\u20131301. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2018.04.006","journal-title":"Alzheimers Dement"},{"key":"1448_CR221","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","volume":"37","author":"YV Taguchi","year":"2017","unstructured":"Taguchi YV, Liu J, Ruan J et al (2017) Glucosylsphingosine promotes \u03b1-synuclein pathology in mutant GBA-associated Parkinson\u2019s disease. J Neurosci 37:9617\u20139631. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1525-17.2017","journal-title":"J Neurosci"},{"key":"1448_CR222","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2017.08.026","volume":"44","author":"LC Guedes","year":"2017","unstructured":"Guedes LC, Chan RB, Gomes MA et al (2017) Serum lipid alterations in GBA-associated Parkinson\u2019s disease. Parkinsonism Relat Disord 44:58\u201365. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2017.08.026","journal-title":"Parkinsonism Relat Disord"},{"key":"1448_CR223","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu Y-H, Sun Y et al (2011) Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146:37\u201352. \n                    https:\/\/doi.org\/10.1016\/j.cell.2011.06.001","journal-title":"Cell"},{"key":"1448_CR224","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fnins.2018.00081","volume":"12","author":"SB Abul Khair","year":"2018","unstructured":"Abul Khair SB, Dhanushkodi NR, Ardah MT et al (2018) Silencing of glucocerebrosidase gene in Drosophila enhances the aggregation of Parkinson\u2019s disease associated \u03b1-synuclein mutant A53T and affects locomotor activity. Front Neurosci 12:81. \n                    https:\/\/doi.org\/10.3389\/fnins.2018.00081","journal-title":"Front Neurosci"},{"key":"1448_CR225","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/14789450.2016.1174583","volume":"13","author":"O Jung","year":"2016","unstructured":"Jung O, Patnaik S, Marugan J et al (2016) Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease. Expert Rev Proteomics 13:471\u2013479. \n                    https:\/\/doi.org\/10.1080\/14789450.2016.1174583","journal-title":"Expert Rev Proteomics"},{"key":"1448_CR226","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1038\/s41598-017-05709-y","volume":"7","author":"A Di Pardo","year":"2017","unstructured":"Di Pardo A, Amico E, Basit A et al (2017) Defective sphingosine-1-phosphate metabolism is a druggable target in Huntington\u2019s disease. Sci Rep 7:5280. \n                    https:\/\/doi.org\/10.1038\/s41598-017-05709-y","journal-title":"Sci Rep"},{"key":"1448_CR227","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3389\/fnins.2017.00698","volume":"11","author":"A Di Pardo","year":"2017","unstructured":"Di Pardo A, Basit A, Armirotti A et al (2017) De novo synthesis of sphingolipids is defective in experimental models of Huntington\u2019s disease. Front Neurosci 11:698. \n                    https:\/\/doi.org\/10.3389\/fnins.2017.00698","journal-title":"Front Neurosci"},{"key":"1448_CR228","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/jnc.14468","volume":"146","author":"M Hunter","year":"2018","unstructured":"Hunter M, Demarais NJ, Faull RLM et al (2018) Subventricular zone lipidomic architecture loss in Huntington\u2019s disease. J Neurochem 146:613\u2013630. \n                    https:\/\/doi.org\/10.1111\/jnc.14468","journal-title":"J Neurochem"},{"key":"1448_CR229","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nmeth.3940","volume":"13","author":"L Pirhaji","year":"2016","unstructured":"Pirhaji L, Milani P, Leidl M et al (2016) Revealing disease-associated pathways by network integration of untargeted metabolomics. Nat Methods 13:770\u2013776. \n                    https:\/\/doi.org\/10.1038\/nmeth.3940","journal-title":"Nat Methods"},{"key":"1448_CR230","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41467-017-00353-6","volume":"8","author":"L Pirhaji","year":"2017","unstructured":"Pirhaji L, Milani P, Dalin S et al (2017) Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements. Nat Commun 8:623. \n                    https:\/\/doi.org\/10.1038\/s41467-017-00353-6","journal-title":"Nat Commun"},{"key":"1448_CR231","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"1448_CR232","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","volume":"23","author":"A Di Pardo","year":"2014","unstructured":"Di Pardo A, Amico E, Favellato M et al (2014) FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. Hum Mol Genet 23:2251\u20132265. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt615","journal-title":"Hum Mol Genet"},{"key":"1448_CR233","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/hmg\/ddy153","volume":"27","author":"A Di Pardo","year":"2018","unstructured":"Di Pardo A, Castaldo S, Amico E et al (2018) Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington\u2019s disease. Hum Mol Genet 27:2490\u20132501. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddy153","journal-title":"Hum Mol Genet"},{"key":"1448_CR234","doi-asserted-by":"publisher","unstructured":"Miguez A, Garc\u00eda-D\u00edaz Barriga G, Brito V, Straccia M, Giralt A, Gin\u00e9s S, Canals JM, Alberch J (2015) Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington\u2019s disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation. Hum Mol Genet 24(17):4958\u20134970. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddv218","DOI":"10.1093\/hmg\/ddv218"},{"key":"1448_CR235","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tips.2018.02.009","volume":"39","author":"A Di Pardo","year":"2018","unstructured":"Di Pardo A, Maglione V (2018) The S1P axis: new exciting route for treating Huntington\u2019s disease. Trends Pharmacol Sci 39:468\u2013480. \n                    https:\/\/doi.org\/10.1016\/j.tips.2018.02.009","journal-title":"Trends Pharmacol Sci"},{"key":"1448_CR236","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1093\/hmg\/ddv439","volume":"24","author":"A Henriques","year":"2015","unstructured":"Henriques A, Croixmarie V, Priestman DA et al (2015) Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase. Hum Mol Genet 24:7390\u20137405. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddv439","journal-title":"Hum Mol Genet"},{"key":"1448_CR237","doi-asserted-by":"publisher","first-page":"8100","DOI":"10.1073\/pnas.1508767112","volume":"112","author":"JC Dodge","year":"2015","unstructured":"Dodge JC, Treleaven CM, Pacheco J et al (2015) Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 112:8100\u20138105. \n                    https:\/\/doi.org\/10.1073\/pnas.1508767112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1448_CR238","doi-asserted-by":"publisher","unstructured":"Henriques A, Croixmarie V, Bouscary A, Mosbach A, Keime C, Boursier-Neyret C, Walter B, Spedding M et al (2018) Sphingolipid metabolism is dysregulated at transcriptomic and metabolic levels in the spinal cord of an animal model of amyotrophic lateral sclerosis. Front Mol Neurosci 10:433. \n                    https:\/\/doi.org\/10.3389\/fnmol.2017.00433","DOI":"10.3389\/fnmol.2017.00433"},{"key":"1448_CR239","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s13311-016-0462-2","volume":"13","author":"RL Potenza","year":"2016","unstructured":"Potenza RL, De Simone R, Armida M et al (2016) Fingolimod: a disease-modifier drug in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics 13:918\u2013927. \n                    https:\/\/doi.org\/10.1007\/s13311-016-0462-2","journal-title":"Neurotherapeutics"},{"key":"1448_CR240","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/00207454.2016.1209754","volume":"127","author":"MS Batistela","year":"2017","unstructured":"Batistela MS, Josviak ND, Sulzbach CD, de Souza RLR (2017) An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer\u2019s and Parkinson\u2019s diseases. Int J Neurosci 127:547\u2013558. \n                    https:\/\/doi.org\/10.1080\/00207454.2016.1209754","journal-title":"Int J Neurosci"},{"key":"1448_CR241","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/1570159X14666160709001441","volume":"15","author":"WD Nadim","year":"2017","unstructured":"Nadim WD, Simion V, Benedetti H et al (2017) MicroRNAs in neurocognitive dysfunctions: new molecular targets for pharmacological treatments? Curr Neuropharmacol 15:260\u2013275","journal-title":"Curr Neuropharmacol"},{"key":"1448_CR242","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/bs.ircmb.2017.04.002","volume":"334","author":"S Quinlan","year":"2017","unstructured":"Quinlan S, Kenny A, Medina M et al (2017) MicroRNAs in neurodegenerative diseases. Int Rev Cell Mol Biol 334:309\u2013343. \n                    https:\/\/doi.org\/10.1016\/bs.ircmb.2017.04.002","journal-title":"Int Rev Cell Mol Biol"},{"key":"1448_CR243","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2009.04.052","volume":"459","author":"P Sethi","year":"2009","unstructured":"Sethi P, Lukiw WJ (2009) Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer\u2019s disease temporal lobe neocortex. Neurosci Lett 459:100\u2013104. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2009.04.052","journal-title":"Neurosci Lett"},{"key":"1448_CR244","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2011.05.044","volume":"499","author":"YY Li","year":"2011","unstructured":"Li YY, Cui JG, Dua P et al (2011) Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells. Neurosci Lett 499:109\u2013113. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2011.05.044","journal-title":"Neurosci Lett"},{"key":"1448_CR245","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainres.2016.05.026","volume":"1646","author":"S Sarkar","year":"2016","unstructured":"Sarkar S, Jun S, Rellick S et al (2016) Expression of microRNA-34a in Alzheimer\u2019s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res 1646:139\u2013151. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2016.05.026","journal-title":"Brain Res"},{"key":"1448_CR246","doi-asserted-by":"publisher","first-page":"509306","DOI":"10.1155\/2015\/509306","volume":"2015","author":"AL Aloia","year":"2015","unstructured":"Aloia AL, Abraham AM, Bonder CS et al (2015) Dengue virus-induced inflammation of the endothelium and the potential roles of sphingosine kinase-1 and microRNAs. Mediat Inflamm 2015:509306. \n                    https:\/\/doi.org\/10.1155\/2015\/509306","journal-title":"Mediat Inflamm"},{"key":"1448_CR247","doi-asserted-by":"publisher","first-page":"37043","DOI":"10.18632\/oncotarget.6158","volume":"6","author":"Y Gui","year":"2015","unstructured":"Gui Y, Liu H, Zhang L et al (2015) Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget 6:37043\u201337053. \n                    https:\/\/doi.org\/10.18632\/oncotarget.6158","journal-title":"Oncotarget"},{"key":"1448_CR248","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.4049\/jimmunol.1403028","volume":"194","author":"Q Xin","year":"2015","unstructured":"Xin Q, Li J, Dang J et al (2015) miR-155 deficiency ameliorates autoimmune inflammation of systemic lupus erythematosus by targeting S1pr1 in Faslpr\/lpr mice. J Immunol 194:5437\u20135445. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1403028","journal-title":"J Immunol"},{"key":"1448_CR249","doi-asserted-by":"publisher","unstructured":"Jaber V, Zhao Y, Lukiw WJ (2017) Alterations in micro RNA-messenger RNA (miRNA-mRNA) coupled signaling networks in sporadic Alzheimer\u2019s disease (AD) hippocampal CA1. J Alzheimer\u2019s Dis Park 7: \n                    https:\/\/doi.org\/10.4172\/2161-0460.1000312","DOI":"10.4172\/2161-0460.1000312"},{"key":"1448_CR250","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10571-017-0572-3","volume":"38","author":"AI Pogue","year":"2018","unstructured":"Pogue AI, Lukiw WJ (2018) Up-regulated pro-inflammatory microRNAs (miRNAs) in Alzheimer\u2019s disease (AD) and age-related macular degeneration (AMD). Cell Mol Neurobiol 38:1021\u20131031. \n                    https:\/\/doi.org\/10.1007\/s10571-017-0572-3","journal-title":"Cell Mol Neurobiol"},{"key":"1448_CR251","unstructured":"MIR155 Gene\u2014GeneCards | MIR155 RNA Gene. \n                    https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=MIR155\n                    \n                  . Accessed 23 Jul 2018"},{"key":"1448_CR252","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0006-8993(00)02205-8","volume":"867","author":"EJ Murphy","year":"2000","unstructured":"Murphy EJ, Schapiro MB, Rapoport SI, Shetty HU (2000) Phospholipid composition and levels are altered in Down syndrome brain. Brain Res 867:9\u201318","journal-title":"Brain Res"},{"key":"1448_CR253","unstructured":"Zhao Y, Jaber V, Percy ME, Lukiw WJ (2017) A microRNA cluster (let-7c, miRNA-99a, miRNA-125b, miRNA-155 and miRNA-802) encoded at chr21q21.1-chr21q21.3 and the phenotypic diversity of Down\u2019s syndrome (DS; trisomy 21). J Nat Sci 3:"},{"key":"1448_CR254","doi-asserted-by":"publisher","first-page":"e0127732","DOI":"10.1371\/journal.pone.0127732","volume":"10","author":"K Charkiewicz","year":"2015","unstructured":"Charkiewicz K, Blachnio-Zabielska A, Zbucka-Kretowska M et al (2015) Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome. PLoS One 10:e0127732. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0127732","journal-title":"PLoS One"},{"key":"1448_CR255","doi-asserted-by":"publisher","first-page":"9100","DOI":"10.1007\/s12035-018-1015-y","volume":"55","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Lukiw WJ (2018) Bacteroidetes neurotoxins and inflammatory neurodegeneration. Mol Neurobiol 55:9100\u20139107. \n                    https:\/\/doi.org\/10.1007\/s12035-018-1015-y","journal-title":"Mol Neurobiol"},{"key":"1448_CR256","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mib.2017.12.011","volume":"43","author":"SL Heaver","year":"2018","unstructured":"Heaver SL, Johnson EL, Ley RE (2018) Sphingolipids in host-microbial interactions. Curr Opin Microbiol 43:92\u201399. \n                    https:\/\/doi.org\/10.1016\/j.mib.2017.12.011","journal-title":"Curr Opin Microbiol"},{"key":"1448_CR257","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139\u2013150. \n                    https:\/\/doi.org\/10.1038\/nrm2329","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1448_CR258","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, Xing Y, Harper SQ et al (2008) The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. J Neurosci 28:14341\u201314346. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2390-08.2008","journal-title":"J Neurosci"},{"key":"1448_CR259","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.phrs.2016.05.005","volume":"108","author":"C D\u00edez-Planelles","year":"2016","unstructured":"D\u00edez-Planelles C, S\u00e1nchez-Lozano P, Crespo MC et al (2016) Circulating microRNAs in Huntington\u2019s disease: emerging mediators in metabolic impairment. Pharmacol Res 108:102\u2013110. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2016.05.005","journal-title":"Pharmacol Res"},{"key":"1448_CR260","first-page":"86","volume":"4","author":"E Das","year":"2015","unstructured":"Das E, Jana NR, Bhattacharyya NP (2015) Delayed cell cycle progression in STHdh(Q111)\/Hdh(Q111) cells, a cell model for Huntington\u2019s disease mediated by microRNA-19a, microRNA-146a and microRNA-432. MicroRNA (Shariqah, United Arab Emirates) 4:86\u2013100","journal-title":"MicroRNA (Shariqah, United Arab Emirates)"},{"key":"1448_CR261","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mcn.2017.12.009","volume":"88","author":"RH Reynolds","year":"2018","unstructured":"Reynolds RH, Petersen MH, Willert CW et al (2018) Perturbations in the p53\/miR-34a\/SIRT1 pathway in the R6\/2 Huntington\u2019s disease model. Mol Cell Neurosci 88:118\u2013129. \n                    https:\/\/doi.org\/10.1016\/j.mcn.2017.12.009","journal-title":"Mol Cell Neurosci"},{"key":"1448_CR262","doi-asserted-by":"publisher","first-page":"e0190550","DOI":"10.1371\/journal.pone.0190550","volume":"13","author":"P Langfelder","year":"2018","unstructured":"Langfelder P, Gao F, Wang N et al (2018) MicroRNA signatures of endogenous huntingtin CAG repeat expansion in mice. PLoS One 13:e0190550. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0190550","journal-title":"PLoS One"},{"key":"1448_CR263","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/mds.26457","volume":"30","author":"AG Hoss","year":"2015","unstructured":"Hoss AG, Lagomarsino VN, Frank S et al (2015) Study of plasma-derived miRNAs mimic differences in Huntington\u2019s disease brain. Mov Disord 30:1961\u20131964. \n                    https:\/\/doi.org\/10.1002\/mds.26457","journal-title":"Mov Disord"},{"key":"1448_CR264","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1212\/WNL.0000000000004844","volume":"90","author":"ER Reed","year":"2018","unstructured":"Reed ER, Latourelle JC, Bockholt JH et al (2018) MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study. Neurology 90:e264\u2013e272. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004844","journal-title":"Neurology"},{"key":"1448_CR265","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3390\/ijms19051534","volume":"19","author":"L Di Pietro","year":"2018","unstructured":"Di Pietro L, Lattanzi W, Bernardini C (2018) Skeletal muscle microRNAs as key players in the pathogenesis of amyotrophic lateral sclerosis. Int J Mol Sci 19:1534. \n                    https:\/\/doi.org\/10.3390\/ijms19051534","journal-title":"Int J Mol Sci"},{"key":"1448_CR266","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fnmol.2018.00288","volume":"11","author":"M Liguori","year":"2018","unstructured":"Liguori M, Nuzziello N, Introna A et al (2018) Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 11:288. \n                    https:\/\/doi.org\/10.3389\/fnmol.2018.00288","journal-title":"Front Mol Neurosci"},{"key":"1448_CR267","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fgene.2018.00310","volume":"9","author":"B De Felice","year":"2018","unstructured":"De Felice B, Manfellotto F, Fiorentino G et al (2018) Wide-ranging analysis of microRNA profiles in sporadic amyotrophic lateral sclerosis using next-generation sequencing. Front Genet 9:310. \n                    https:\/\/doi.org\/10.3389\/fgene.2018.00310","journal-title":"Front Genet"},{"key":"1448_CR268","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fnmol.2018.00311","volume":"11","author":"N Gershoni-Emek","year":"2018","unstructured":"Gershoni-Emek N, Altman T, Ionescu A et al (2018) Localization of RNAi machinery to axonal branch points and growth cones is facilitated by mitochondria and is disrupted in ALS. Front Mol Neurosci 11:311. \n                    https:\/\/doi.org\/10.3389\/fnmol.2018.00311","journal-title":"Front Mol Neurosci"},{"key":"1448_CR269","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1093\/brain\/awy182","volume":"141","author":"ML Hoye","year":"2018","unstructured":"Hoye ML, Regan MR, Jensen LA et al (2018) Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis. Brain 141:2561\u20132575. \n                    https:\/\/doi.org\/10.1093\/brain\/awy182","journal-title":"Brain"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1448-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:46:48Z","timestamp":1589881608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1448-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":269,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1448-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,5]]},"assertion":[{"value":"2 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}